[{"authors":["admin"],"categories":null,"content":"I am a Computational Biology Research Scientist with Dr. Felix Feng at UCSF. My primary research location is the UCSF HDFC Cancer Center. Additionally, I hold Adjunct Research Scientist position at the Nepal Applied Mathematics \u0026amp; Informatics Institute for Research (NAAMII), where I am leading the Computational Genomics Laboratory. [My Bio]\nMy main interest lies in understanding cancer progression and treatment resistance through the development and application of computational genomics approaches.\nI am actively looking for academic faculty position.\n","date":1730419200,"expirydate":-62135596800,"kind":"term","lang":"en","lastmod":1730419200,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"/authors/admin/","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/authors/admin/","section":"authors","summary":"I am a Computational Biology Research Scientist with Dr. Felix Feng at UCSF. My primary research location is the UCSF HDFC Cancer Center. Additionally, I hold Adjunct Research Scientist position at the Nepal Applied Mathematics \u0026amp; Informatics Institute for Research (NAAMII), where I am leading the Computational Genomics Laboratory. [My Bio]\nMy main interest lies in understanding cancer progression and treatment resistance through the development and application of computational genomics approaches.","tags":null,"title":"Raunak Shrestha","type":"authors"},{"authors":null,"categories":null,"content":"Flexibility This feature can be used for publishing content such as:\nOnline courses Project or software documentation Tutorials The courses folder may be renamed. For example, we can rename it to docs for software/project documentation or tutorials for creating an online course.\nDelete tutorials To remove these pages, delete the courses folder and see below to delete the associated menu link.\nUpdate site menu After renaming or deleting the courses folder, you may wish to update any [[main]] menu links to it by editing your menu configuration at config/_default/menus.toml.\nFor example, if you delete this folder, you can remove the following from your menu configuration:\n[[main]] name = \u0026#34;Courses\u0026#34; url = \u0026#34;courses/\u0026#34; weight = 50 Or, if you are creating a software documentation site, you can rename the courses folder to docs and update the associated Courses menu configuration to:\n[[main]] name = \u0026#34;Docs\u0026#34; url = \u0026#34;docs/\u0026#34; weight = 50 Update the docs menu If you use the docs layout, note that the name of the menu in the front matter should be in the form [menu.X] where X is the folder name. Hence, if you rename the courses/example/ folder, you should also rename the menu definitions in the front matter of files within courses/example/ from [menu.example] to [menu.\u0026lt;NewFolderName\u0026gt;].\n","date":1536451200,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1536451200,"objectID":"01d39688af48040d7111d20c6b01d10b","permalink":"/courses/example.1/","publishdate":"2018-09-09T00:00:00Z","relpermalink":"/courses/example.1/","section":"courses","summary":"Learn how to use Academia's docs layout for publishing online courses, software documentation, and tutorials.","tags":null,"title":"Overview 2","type":"docs"},{"authors":null,"categories":null,"content":"Flexibility This feature can be used for publishing content such as:\nOnline courses Project or software documentation Tutorials The courses folder may be renamed. For example, we can rename it to docs for software/project documentation or tutorials for creating an online course.\nDelete tutorials To remove these pages, delete the courses folder and see below to delete the associated menu link.\nUpdate site menu After renaming or deleting the courses folder, you may wish to update any [[main]] menu links to it by editing your menu configuration at config/_default/menus.toml.\nFor example, if you delete this folder, you can remove the following from your menu configuration:\n[[main]] name = \u0026#34;Courses\u0026#34; url = \u0026#34;courses/\u0026#34; weight = 50 Or, if you are creating a software documentation site, you can rename the courses folder to docs and update the associated Courses menu configuration to:\n[[main]] name = \u0026#34;Docs\u0026#34; url = \u0026#34;docs/\u0026#34; weight = 50 Update the docs menu If you use the docs layout, note that the name of the menu in the front matter should be in the form [menu.X] where X is the folder name. Hence, if you rename the courses/example/ folder, you should also rename the menu definitions in the front matter of files within courses/example/ from [menu.example] to [menu.\u0026lt;NewFolderName\u0026gt;].\n","date":1536451200,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1536451200,"objectID":"970b63766f241ba034ef2d1838dad4b3","permalink":"/courses/example.2/","publishdate":"2018-09-09T00:00:00Z","relpermalink":"/courses/example.2/","section":"courses","summary":"Learn how to use Academia's docs layout for publishing online courses, software documentation, and tutorials.","tags":null,"title":"Overview 3","type":"docs"},{"authors":null,"categories":null,"content":"Flexibility This feature can be used for publishing content such as:\nOnline courses Project or software documentation Tutorials The courses folder may be renamed. For example, we can rename it to docs for software/project documentation or tutorials for creating an online course.\nDelete tutorials To remove these pages, delete the courses folder and see below to delete the associated menu link.\nUpdate site menu After renaming or deleting the courses folder, you may wish to update any [[main]] menu links to it by editing your menu configuration at config/_default/menus.toml.\nFor example, if you delete this folder, you can remove the following from your menu configuration:\n[[main]] name = \u0026#34;Courses\u0026#34; url = \u0026#34;courses/\u0026#34; weight = 50 Or, if you are creating a software documentation site, you can rename the courses folder to docs and update the associated Courses menu configuration to:\n[[main]] name = \u0026#34;Docs\u0026#34; url = \u0026#34;docs/\u0026#34; weight = 50 Update the docs menu If you use the docs layout, note that the name of the menu in the front matter should be in the form [menu.X] where X is the folder name. Hence, if you rename the courses/example/ folder, you should also rename the menu definitions in the front matter of files within courses/example/ from [menu.example] to [menu.\u0026lt;NewFolderName\u0026gt;].\n","date":1536451200,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1536451200,"objectID":"59c3ce8e202293146a8a934d37a4070b","permalink":"/courses/example/","publishdate":"2018-09-09T00:00:00Z","relpermalink":"/courses/example/","section":"courses","summary":"Learn how to use Academia's docs layout for publishing online courses, software documentation, and tutorials.","tags":null,"title":"Overview","type":"docs"},{"authors":null,"categories":null,"content":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academia:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"74533bae41439377bd30f645c4677a27","permalink":"/courses/example/example1/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example1/","section":"courses","summary":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academia:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim.","tags":null,"title":"Example Page 1","type":"docs"},{"authors":null,"categories":null,"content":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academia:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"883c5cf2007b50b720ce5f4a17b72261","permalink":"/courses/example.1/example3/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example.1/example3/","section":"courses","summary":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academia:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim.","tags":null,"title":"Example Page 1","type":"docs"},{"authors":null,"categories":null,"content":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academia:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"32df3afea9008eacfc678398fd6443ad","permalink":"/courses/example.2/example3/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example.2/example3/","section":"courses","summary":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academia:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim.","tags":null,"title":"Example Page 1","type":"docs"},{"authors":null,"categories":null,"content":"Here are some more tips for getting started with academia:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"ae73c2dafb9eed90c8870cdf783e948c","permalink":"/courses/example.2/example4/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example.2/example4/","section":"courses","summary":"Here are some more tips for getting started with academia:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus.","tags":null,"title":"Example Page 2","type":"docs"},{"authors":null,"categories":null,"content":"Here are some more tips for getting started with academia:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"1c2b5a11257c768c90d5050637d77d6a","permalink":"/courses/example/example2/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example2/","section":"courses","summary":"Here are some more tips for getting started with academia:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus.","tags":null,"title":"Example Page 2","type":"docs"},{"authors":null,"categories":null,"content":"Here are some more tips for getting started with academia:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"507e4cd2746d8b7ea0b6ed4a42cb4462","permalink":"/courses/example.1/example4/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example.1/example4/","section":"courses","summary":"Here are some more tips for getting started with academia:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus.","tags":null,"title":"Example Page 2","type":"docs"},{"authors":["LN Chesner","F Polesso","JN Graff","JE Hawley","AK Smith","A Lundberg","R Das","T Shenoy","M Sjostrom","F Zhao","Y Hu","S Linder","WS Chen","ReM Hawkins","admni","X Zhu","A Foye","H Li","LM Kim","M Bhalla","T O'loughlin","D Kuzuoglu-Ozturk","J T Hua","ML Badura","S Wilkinson","SY Trostel","AM Bergman","D Ruggero","CG Drake","AG Sowalsky","L Fong","MR Cooperberg","W Zwart","X Guan","A Ashworth","Z Xia","DA Quigley","LA Gilbert","FY Feng","AE Moran"],"categories":null,"content":"","date":1733356800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1733356800,"objectID":"a328a140f8849c978625eadabf47985b","permalink":"/publication/2024_mhc/","publishdate":"2024-12-05T00:00:00Z","relpermalink":"/publication/2024_mhc/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer","type":"publication"},{"authors":["Raunak Shrestha"],"categories":[],"content":" The GESD statistical test can be used to answer the following question: How many outliers does the data set contain?\nHere, I present an implementation of GESD test written in R which can be accessed using the following url: https://github.com/raunakms/GESD\nGeneralized Extreme Studentized Deviate (GESD) test The generalized (extreme Studentized deviate) ESD test (Rosner 1983) is a statistical method used to detect one or more outliers in a univariate data set that follows an approximately normal distribution. The primary limitation of the Grubbs test and the Tietjen-Moore test is that the suspected number of outliers, $k$, must be specified exactly. If $k$ is not specified correctly, this can distort the conclusions of these tests. On the other hand, the generalized ESD test (Rosner 1983) only requires that an upper bound for the suspected number of outliers be specified.\nGiven the upper bound, $r$, the generalized ESD test essentially performs $r$ separate tests: a test for one outlier, a test for two outliers, and so on up to $r$ outliers.\nThe generalized ESD test is defined for the hypothesis: $H_{0}$: There are no outliers in the data set $H_{a}$: There are up to r outliers in the data set Test Statistic: Compute $$R_{i} = \\frac{max_{i}|x_{i} - \\bar{x}|}{s} $$ with $x$ and $s$ denoting the sample mean and sample standard deviation, respectively. Remove the observation that maximizes $|x_{i} - \\bar{x}|$ and then recompute the above statistic with $n-1$ observations. Repeat this process until $r$ observations have been removed. This results in the $r$ test statistics $R_{1}, R_{2}, \u0026hellip;, R_{r}$.\nSignificance Level: alpha $(\\alpha)$\nCritical Region: Corresponding to the $r$ test statistics, compute the following $r$ critical values $$ \\lambda_{i} = \\frac{(n-i) * t_{n-i-1,p}}{ \\sqrt{(n-i-1 + t^2_{n-i-1,p})*(n-i+1)} } $$\nwhere $i = 1, 2, \u0026hellip;, r$, and $t_{d,p}$ is the $p^{th}$ percentile of a $t$ distribution with $d$ degrees of freedom.\n$$ p = 1 - \\frac{\\alpha}{2*(n-i+1)} $$\nThe number of outliers is determined by finding the largest $i$ such that $ R_{i} \u0026gt; \\lambda_{i} $. Simulation studies by Rosner indicate that this critical value approximation is very accurate for $n \\ge 25$ and reasonably accurate for $n \\ge 15$.\nNote that although the generalized ESD is essentially Grubbs test applied sequentially, there are a few important distinctions:\nThe generalized ESD test makes appropriate adjustments for the critical values based on the number of outliers being tested for that the sequential application of Grubbs test does not. If there is significant masking, applying Grubbs test sequentially may stop too soon. The example below identifies three outliers at the 5% level when using the generalized ESD test. However, trying to use Grubbs test sequentially would stop at the first iteration and declare no outliers. Original Paper Citation B. Rosner (1983). Percentage Points for a Generalized ESD Many-Outlier Procedure. Technometrics 25(2), pp. 165-172. http://www.jstor.org/stable/1268549?seq=1 Decription Computes outliers for the given data using GESD statistics.\nUsage gesd(obs, alpha, value.zscore, r) Arguments $obs$ : a vector of observation $alpha$ : significance Level $value.zscore$ : if the observation value are already z-normalized. Takes values \u0026ldquo;YES\u0026rdquo; or \u0026ldquo;NO\u0026rdquo;. $r$ : upperbound to the number of observations to call as an outlier. If NA, computes GESD test statistic until values of half sample size have been removed from the sample. Value Total : The first column gives the total number of outliers Rest of the columns are for each observation Value of the outlier indicates the outlier rank in the acending order where 0 inidicates not an outlier, 1 inidicate the highest ranked outlier (i.e. most extreme observation). R-code Below is the R-code of the function that implements GESD test\ngesd \u0026lt;- function(obs, alpha, value.zscore=NA, r=NA) { #### Define and Declare Variables #### n \u0026lt;- length(obs) if(is.na(r)){r \u0026lt;- floor(n/2)} # by default, set upper bound on number of outliers \u0026#39;r\u0026#39; to 1/2 sample size R \u0026lt;- numeric(length=r) # test statistics for \u0026#39;r\u0026#39; outliers lambda \u0026lt;- numeric(length=r) # critical values for \u0026#39;r\u0026#39; outliers outlier_ind \u0026lt;- numeric(length=r) # removed outlier observation values outlier_val \u0026lt;- numeric(length=r) # removed outlier observation values m \u0026lt;- 0 # number of outliers obs_new \u0026lt;- obs # temporary observation values #### Find outliers #### for(i in 1:r){ #### Compute test statistic #### if((value.zscore == \u0026#34;YES\u0026#34;) | (value.zscore == \u0026#34;Y\u0026#34;)){ z \u0026lt;- abs(obs_new) # If Z-score is alrealy computed }else if((value.zscore == \u0026#34;NO\u0026#34;) | (value.zscore == \u0026#34;N\u0026#34;)){ z \u0026lt;- abs(obs_new - mean(obs_new))/sd(obs_new) # Z-scores } else{ print(\u0026#34;ERROR! Inappropriate value for value.score=[YES|NO]\u0026#34;) } max_ind \u0026lt;- which(z==max(z),arr.ind=T)[1] # in case of ties, return first one R[i] \u0026lt;- z[max_ind] # max Z-score outlier_val[i] \u0026lt;- obs_new[max_ind] # removed outlier observation values outlier_ind[i] \u0026lt;- which(obs_new[max_ind] == obs, arr.ind=T)[1] # index of removed outlier observation values obs_new \u0026lt;- obs_new[-max_ind] # remove observation that maximizes |x_i - x_mean| #### Compute critical values #### ##n_obs \u0026lt;- length(obs_new) # subset sample size p \u0026lt;- 1 - alpha/(2*(n-i+1)) # probability t_pv \u0026lt;- qt(p,df=(n-i-1)) # Critical value from Student\u0026#39;s t distribution lambda[i] \u0026lt;- ((n-i)*t_pv) / (sqrt((n-i-1+t_pv^2)*(n-i+1))) #### Find exact number of outliers: largest \u0026#39;i\u0026#39; such that R_i \u0026gt; lambda_i #### # print(c(i, R[i], lambda[i])) # try ((R[i] \u0026gt; lambda[i]), finally \u0026lt;- print(c(i, R[i], lambda[i])) # ) if(!is.na(R[i]) \u0026amp; !is.na(lambda[i])) { # qt can produce NaNs if (R[i] \u0026gt; lambda[i]) { m \u0026lt;- i } # else { # break # } } } vals \u0026lt;- data.frame(NumOutliers=1:r, TestStatistic=R, CriticalValue=lambda) # print(vals) #### Rank outlier observations #### outlier_rank \u0026lt;- numeric(length=n) if (m \u0026gt; 0) { for (i in 1:m) { # outlier_rank[outlier_ind[i]] \u0026lt;- i outlier_rank[which(obs==outlier_val[i])] \u0026lt;- i } } num_outliers \u0026lt;- sum(outlier_rank != 0) #14 and 25 missing res \u0026lt;- c(num_outliers, outlier_rank) names(res) \u0026lt;- c(\u0026#34;Total\u0026#34;, names(obs)) return(res)\t} ","date":1730419200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1730419200,"objectID":"5c71be37521889260796d94f438901e0","permalink":"/post/gesd/","publishdate":"2024-11-01T00:00:00Z","relpermalink":"/post/gesd/","section":"post","summary":"Implementation of GESD test in R","tags":["statistics"],"title":"Generalized Extreme Studentized Deviate (GESD) test to detect outliers in R","type":"post"},{"authors":[],"categories":null,"content":"","date":1729674000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1729674000,"objectID":"4ae2c734bf0de2db02901f2525863517","permalink":"/talk/20241023_pcf_retreat/","publishdate":"2024-07-28T00:00:00Z","relpermalink":"/talk/20241023_pcf_retreat/","section":"talk","summary":"","tags":[],"title":"31st Annual PCF Scientific Retreat","type":"talk"},{"authors":["X Zhu","T Farsh","D Vis","I Yu","H Li","T Liu","M Sjostrom","Raunak Shrestha","J Kneppers","T Severson","MmZhang","A Lundberg","TM Rodriguez","AS Weinstein","A Foye","N Mehra","RR Aggarwal","AM Bergman","EJ Small","NA Lack","W Zwart","DA Quigley","MS Heijden","FY Feng"],"categories":null,"content":"","date":1723507200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1723507200,"objectID":"d772412d062e69cde26d2b2cf6216473","permalink":"/publication/2024_prepost/","publishdate":"2024-08-13T00:00:00Z","relpermalink":"/publication/2024_prepost/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer","type":"publication"},{"authors":["Raunak Shrestha","LN Chesner","M Zhang","S Zhou","A Foye","A Lundberg","AS Weinstein","M Sjostrom","X Zhu","T Moreno-Rodriguez","H Li","JJ Alumkal","R Aggarwal","EJ Small","M Lupien","DA Quigley","FY Feng"],"categories":null,"content":"Thrilled! Our study \u0026quot;An Atlas of Accessible Chromatin in Advanced Prostate Cancer..\u0026quot; is now online @CR_AACR\nThank you @felixfengmd @David_A_Quigley @MatLupien for amazing mentorship \u0026amp; @PCF_science, the Benioff Institute, @UCSFCancer for their support! https://t.co/O2zTlzCsqh\n\u0026mdash; Raunak Shrestha, PhD (@raunakms) July 11, 2024 ","date":1720656000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1720656000,"objectID":"876a7959e6754e43c9c48eaec464b44b","permalink":"/publication/2024_wcdt_atacseq/","publishdate":"2024-07-11T00:00:00Z","relpermalink":"/publication/2024_wcdt_atacseq/","section":"publication","summary":"Integration of a large cohort of transcriptome, whole genome, and ATAC-sequencing characterizes the chromatin accessibility changes in advanced prostate cancer and identifies therapy-resistant prostate cancer subtype-specific transcription factors that modulate oncogenic programs.","tags":["Cancer","Prostate cancer"],"title":"An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression","type":"publication"},{"authors":["S Zhao","M Bootsma","S Zhou","Raunak Shrestha","T Moreno-Rodriguez","A Lundberg","C Pan","C Arlidge","J Hawley","A Foye","A Weinstein","M Sjostrom","M Zhang","H Li","LN Chesner","N Rydzewski","K Helzer","Y Shi","S Dehm","J Lang","J Alumkal","H He","A Wyatt","R Aggarwal","W Zwart","E Small","D Quigley","M Lupien","FY Feng"],"categories":null,"content":"","date":1717891200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1717891200,"objectID":"a6d13200485af4effbadc9d902d2fb03","permalink":"/publication/2024_wcdt_hic/","publishdate":"2024-06-09T00:00:00Z","relpermalink":"/publication/2024_wcdt_hic/","section":"publication","summary":"We discovered a group of metastatic prostate cancer patients with lower levels of DNA-DNA interactions around the Androgen Receptor (AR) gene, the main driver of prostate cancer. Interestingly, this group had an abundance of circular DNA outside of the chromosomes (extrachromosomal circular DNA (ecDNA)) that included parts of the AR gene resulting in AR gene amplification and become very active, which might explain why their cancer was resistant to treatment.","tags":["Cancer","Prostate cancer"],"title":"Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer","type":"publication"},{"authors":["M Zhang","M Sjostrom","X Cui","A Foye","K Farh","Raunak Shrestha","A Lundberg","HX Dang","PG Febbo","R Aggarwal","J Alkumal","EJ Small","CA Maher","FY Feng","DA Quigley"],"categories":null,"content":"","date":1717891200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1717891200,"objectID":"fd89273aeafd9702407a043190b01486","permalink":"/publication/2024_alternative_promoter/","publishdate":"2024-06-09T00:00:00Z","relpermalink":"/publication/2024_alternative_promoter/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression","type":"publication"},{"authors":[],"categories":null,"content":"","date":1712307600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1712307600,"objectID":"409b9e5af76019a0393528c7bb535bdc","permalink":"/talk/20240405_aacr/","publishdate":"2024-02-24T00:00:00Z","relpermalink":"/talk/20240405_aacr/","section":"talk","summary":"","tags":[],"title":"AACR Annual Meeting 2024","type":"talk"},{"authors":null,"categories":null,"content":"Investigating Type-2 Diabetes Associated Gut Microbiome Diversity in Nepalese Population Type-2 diabetes (T2D) has emerged as a global health challenge, affecting millions of people worldwide. Nepal bears a substantial T2D burden and it is a prominent cause of mortality in adults. Increasing urbanization and changing lifestyles have directly contributed to a surge in T2D cases in Nepal.\nT2D is characterized by elevated blood glucose levels resulting from insufficient insulin production to effectively regulate glucose utilization in the body. It is a complex disease influenced by genetic and environmental factors, notably diet and physical activity. Consuming excessive amounts of refined sugars and processed foods increases the risk of developing T2D.\nGeography and diet play a substantial role in shaping gut microbiome, which, in turn, is associated with T2D progression. While many investigations have focused on diabetic populations in Western nations, the gut microbiome of South Asian populations diverges notably from that of Western populations, largely due to differences in dietary composition. To comprehensively identify T2D-associated gut microbiomes, we propose investigating the diversity of gut microbiomes among the T2D population in Nepal, alongside leveraging publicly available T2D gut microbiome cohorts from different countries. Our study will help develop preventive and treatment strategies tailored to specific populations, mitigating health disparities in diabetes research.\n","date":1711929600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1711929600,"objectID":"b7f16b18bfbd355fdd2a0eb0ac01f3e8","permalink":"/research_naamii/t2d_microbiome/","publishdate":"2024-04-01T00:00:00Z","relpermalink":"/research_naamii/t2d_microbiome/","section":"research_naamii","summary":"Investigating biomarkers of Type-2 diabetes and insulin resistance","tags":["T2D","Diabetes","Machine Learning","Systems Genomics","Non-Communicable Disease"],"title":"Insulin Resistance in Diabetes","type":"research_naamii"},{"authors":["Raunak Shrestha"],"categories":["machine learning"],"content":"Artificial Intelligence (AI) or Machine learning (ML) combines computer science with statistics and enables computers to learn from data and make decisions or predictions without being explicitly programmed to do so. AI has revolutionized numerous sectors within biotechnology, here I will highlight a few notable applications specifically in genomics and medicine.\nAll living organisms store their genetic instructions in Deoxyribonucleic acid (DNA), built from the same four building blocks (nucleotides) but arranged in different sequential combinations. DNA contains the biological instructions, while proteins carry out the functions encoded within it. DNA sequencing technology enables the identification of the sequential arrangement of DNA. With the rapid advancements in DNA sequencing technology, the cost of sequencing has plummeted to less than 1000 US Dollars per human genome. Consequently, more and more genomes are being sequenced and there has been a remarkable expansion in the volume of publicly available DNA sequencing data. A new scientific discipline emerged to extract valuable insights from this vast amount of data: Bioinformatics. It integrates principles from both biology and information technology to enhance our understanding of biological processes.\nWhy AI is required in genomics? Genomics data is vast and complex, encompassing multi-omics data of the genome, transcriptome, proteome, and epigenome. These datasets offer complementary insights into biological systems, forming intricate hierarchical relationships, often nonlinear. Moreover, the precise mechanisms governing gene regulation still need to be explained.\nThe declining cost of sequencing has enabled measuring many data points per patient for a large patient population. AI algorithms have emerged as powerful tools for processing and analyzing large-scale datasets, extracting meaningful patterns, and revealing correlations that may elude traditional statistical approaches. They can predict outcomes, classify sequences, and identify patterns within genomic data. This capability is essential for tasks such as identifying disease markers, predicting patient responses to treatments, and classifying genetic mutations. AI techniques enable the integration and analysis of diverse omics datasets to gain a comprehensive understanding of biological systems and diseases.\nFueled by the explosion of biological data, all major biotech and pharma companies are embracing bioinformatics and AI to accelerate and optimize their research efforts. Moreover, major global IT companies such as Google, IBM, Microsoft, and Amazon have dedicated workforces in genomics and medicine working on AI-based technologies.\nApplications of AI in genomics and medicine One of the most prominent applications of AI in genomics is in genome sequence analysis. Sequencing technologies generate massive amounts of data, which require sophisticated computational approaches to analyze and interpret. AI algorithms, such as deep learning, can identify patterns within these large datasets. For example, Oxford Nanopore’s Guppy [1] leverages a deep learning model to translate the raw electronic signal generated by its DNA sequencer into bases. Google’s DeepVariant [2] uses a deep learning model to call genetic variants from high-throughput DNA sequencing data with higher accuracy than traditional methods. By accurately identifying variations in genomic sequences, researchers can better understand genetic predispositions to diseases and develop more personalized medical treatments.\nAnother impactful application of AI in genomics lies in disease prediction. By analyzing large datasets of patients\u0026rsquo; genetic information and medical records, AI algorithms can identify patterns that associate specific genetic variants with an increased risk of developing certain diseases. For example, in oncology, AI models are being trained to predict a patient\u0026rsquo;s risk of developing specific cancers based on their genetic profile [3]. Using DNA obtained from blood samples, AI algorithms can predict if the patient has cancer or not [4]. This information can then be used for early detection and intervention, potentially saving lives.\nAI has completely revolutionized the drug discovery and development process. AI techniques are used at various stages, from target identification and lead optimization to clinical trial design and patient stratification. Analyzing vast libraries of potential drug molecules and their interactions with biological targets is a daunting task. However, AI algorithms can efficiently sift through this data, identifying promising candidates with the desired properties. This not only accelerates the drug discovery process but also increases the likelihood of finding effective treatments. Using multi-omics profiles from patients, AI models can also predict if a patient will respond to a drug treatment [5,6]. These AI models can potentially help clinicians in appropriate treatment selection and further accelerate aid in precision medicine.\nAntibody-based therapies have gained prominence in the treatment of various diseases, including cancer and autoimmune disorders. AI algorithms can analyze the structural and sequence data of antibodies to predict their binding affinity and selectivity, facilitating the design of antibodies with enhanced therapeutic properties [7]. Many biotech and pharma industries have resorted to AI to engineer desired antibodies for potential therapeutics or vaccines.\nAI has emerged as a powerful tool in the field of protein structure prediction, revolutionizing our ability to accurately predict the three-dimensional structures of proteins from their amino acid sequences. This capability is crucial for understanding protein function, drug discovery, and the design of novel therapeutics. AI algorithms have been applied across various stages of protein structure prediction, from tertiary structure prediction to protein-protein interaction modeling, offering significant advancements in accuracy and efficiency. For instance, DeepMind\u0026rsquo;s AlphaFold [8] project uses AI to predict the 3D structure of proteins using the information of amino acid sequences of the protein alone. AlphaFold has generated structural predictions for millions of proteins, many of which remain undiscovered through other experimental or computational means. This represents perhaps the most significant contribution AI has made to biology, with profound implications for medicine, especially in the imminent advancement of drug development.\nRecent advances in generative AI have also impacted biology and medicine to a greater extent. Generative AI refers to a class of AI algorithms that are designed to generate new content or data that is similar to, but not identical to, existing data. These powerful algorithms are developed by training on expansive datasets, during which they assimilate the fundamental patterns, connections, and frameworks inherent in the data. Essentially, they master the “language” or core patterns that define the underlying data. Using generative AI, scientists can create molecular structures of a novel compound that potentially inhibits the function of a protein of interest and be used for disease treatment [9]. Using generative AI, scientists can also engineer a new protein with a desired function [10]. Furthermore, generative AI has shown promise in personalized medicine by analyzing large-scale genomic and clinical datasets to tailor treatments to individual patients. By leveraging generative models, researchers can simulate the effects of different treatments on patient outcomes, guiding healthcare professionals in making more informed decisions. For example, large language models (LLMs) like OpenAI’s ChatGPT and Google’s PaLM2 are actively trained on vast repositories of patient clinical health records, facilitating researchers in gaining deeper insights into health, disease, and treatment modalities.\nIn summary, the applications of AI in biotechnology and medicine are diverse and far-reaching. The convergence of AI and genomics has ignited a revolution in healthcare, ushering in an era of personalized medicine and accelerated drug discovery. From deciphering complex genetic data to predicting disease risk and designing targeted therapies, AI is unlocking the immense potential of genomics for the betterment of human health. As research in this field continues to evolve at an unprecedented pace, we can anticipate even more transformative applications in the years to come.\nReferences Wick, R. R., Judd, L. M. \u0026amp; Holt, K. E. Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol 20, 129 (2019). Poplin, R. et al. A universal snp and small-indel variant caller using deep neural networks. Nat Biotechnol 36, 983 (2018). Moon, I. et al. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary. Nat Med 29, 2057–2067 (2023). Cristiano, S. et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385–389 (2019). Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C. \u0026amp; Ester, M. MOLI: Multi-omics late integration with deep neural networks for drug response prediction. in Bioinformatics vol. 35 i501–i509 (Oxford University Press, 2019). Sharifi-Noghabi, H., Peng, S., Zolotareva, O., Collins, C. C. \u0026amp; Ester, M. AITL: Adversarial inductive transfer learning with input and output space adaptation for pharmacogenomics. Bioinformatics 36, I380–I388 (2020). Graves, J. et al. A Review of Deep Learning Methods for Antibodies. Antibodies (Basel) 9, (2020). Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021). Jiang, P. et al. Big data in basic and translational cancer research. Nat Rev Cancer 22, 625–639 (2022). Madani, A. et al. Large language models generate functional protein sequences across diverse families. Nat Biotechnol 41, 1099–1106 (2023). ","date":1708560000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1645488000,"objectID":"0303b1508549c25ecc1e6b5e974f10da","permalink":"/post/ai_biotech_medicine/","publishdate":"2024-02-22T00:00:00Z","relpermalink":"/post/ai_biotech_medicine/","section":"post","summary":"AI/ML combines computer science with statistics and enables computers to learn from data and make decisions or predictions without being explicitly programmed to do so. AI has revolutionized numerous sectors within biotechnology, here I will highlight a few notable applications specifically in genomics and medicine.","tags":["machine learning","genomics","biotechnology","medicine"],"title":"Applications of Artificial Intelligence in Biotechnology and Medicine","type":"post"},{"authors":[],"categories":null,"content":"","date":1698224400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1698224400,"objectID":"090bc0e0c8d8b7e987a05f70bb8423ed","permalink":"/talk/20231025_pcf_retreat/","publishdate":"2023-07-28T00:00:00Z","relpermalink":"/talk/20231025_pcf_retreat/","section":"talk","summary":"","tags":[],"title":"30th Annual PCF Scientific Retreat","type":"talk"},{"authors":null,"categories":null,"content":"Biomarkers of HPV-negative head and neck cancer Approximately 10% of worldwide cancer cases are linked to viruses. Human papillomavirus (HPV) infection is specifically associated with both cervical cancer and Head and Neck Cancer (HNC), often sexually transmitted. In Nepal, cervical cancer stands out as one of the most commonly diagnosed cancers in women, while HNC ranks as a significant contributor to cancer morbidity in both sexes. HPV infection is identified in nearly all cervical cases. In contrast, about 70% of HNC cases exhibit HPV infections, with the remaining 30% linked to factors such as smoking and alcohol/tobacco consumption, rendering them HPV-negative. The presence or absence of HPV infection in HNC is closely tied to disease prognosis and significantly influences treatment approaches. In cervical cancer and HNC, the virus integrates into the host genome, activating E6/E7 oncoproteins that dysregulate cell-cycle regulation and promote uncontrolled cell proliferation. The risk of HPV-mediated cancers is significantly lowered through HPV vaccination, contributing to a global decrease in its incidence. HPV vaccination campaign globally decreases the prevalence of HPV-positive HNC, leading to a potential increase in HPV-negative HNC in the future. HPV-negative HNC cancers are genetically different than HPV-mediated cancers, often presenting as more advanced disease at the time of diagnosis and less responsive to standard-of-care treatments. Therefore, it is crucial to discern the genomic predictors of HPV-negative cancers that can aid in early detection and disease prognosis prediction. In this study, we will identify genomic predictors of HPV-positive and HPV-negative cancers using machine learning models trained in multi-omics data from both cervical cancer and HNC.\n","date":1696118400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1696118400,"objectID":"8d6d6d28c9210326e26cdf45d73bda9e","permalink":"/research_naamii/hpv_cancer_genomics/","publishdate":"2023-10-01T00:00:00Z","relpermalink":"/research_naamii/hpv_cancer_genomics/","section":"research_naamii","summary":"Biomarkers of HPV-negative head and neck cancer","tags":["Cancer","HPV","Machine Learning","Cervical cancer","Head and neck cancer","Non-Communicable Disease"],"title":"HPV-mediated Cancers","type":"research_naamii"},{"authors":[],"categories":null,"content":"","date":1691226000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1691226000,"objectID":"96109387319f30a2d10fcd3c1c91a554","permalink":"/talk/20230805_gordon_prostate/","publishdate":"2023-07-28T00:00:00Z","relpermalink":"/talk/20230805_gordon_prostate/","section":"talk","summary":"","tags":[],"title":"2023 Gordon Research Conference - Hormone-Dependent Cancers","type":"talk"},{"authors":["A Lundberg","M Zhang","R Aggarwal","H Li","L Zhang","A Foye","M Sjostrom","J Chou","K Chang","T Moreno-Rodriguez","Raunak Shrestha","A Baskin","X Zhu","AS Weinstein","N Younger","JJ Alumkal","TM Beer","KN Chi","CP Evans","M Gleave","PN Lara","RE Reiter","MB Rettig","ON Witte","AW Wyatt","FY Feng","EJ Small","DA Quigley"],"categories":null,"content":"","date":1686182400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1686182400,"objectID":"7251300d6738d2e73260026ac33b08c8","permalink":"/publication/2023_dnpc/","publishdate":"2023-06-08T00:00:00Z","relpermalink":"/publication/2023_dnpc/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"The genomic and epigenomic landscape of double-negative metastatic prostate cancer","type":"publication"},{"authors":["RK Shrestha","Raunak Shrestha","S Shneiderman","J Baniya"],"categories":null,"content":"","date":1679097600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1679097600,"objectID":"e998754d6e0d9e5dd320db969f46fb4e","permalink":"/publication/2023_happiness/","publishdate":"2023-03-18T00:00:00Z","relpermalink":"/publication/2023_happiness/","section":"publication","summary":"","tags":null,"title":"Beyond Reconstruction: What Leads to Satisfaction in Post-Disaster Recovery?","type":"publication"},{"authors":null,"categories":null,"content":"Systems Genomics Modelling of Drug Resistance in Mycobacterium tuberculosis Multi-drug resistance presents a growing challenge to global tuberculosis (TB) control efforts, with a particularly pressing concern in developing nations where robust disease surveillance and monitoring are lacking. Nepal is one of the countries with a high TB burden. TB is caused by an airborne bacterium, Mycobacterium tuberculosis (Mtb). Treatment for TB involves antibiotics, however, some Mtb becomes resistant to these drugs, forming drug-resistant TB, which is rapidly increasing and poses a major health threat. The emergence of drug resistance TB is linked to specific mutations in Mtb genome. However, the genetic foundations of drug resistance in TB are not fully understood. The existing catalog of well-characterized Mtb drug-resistant mutations falls short in elucidating numerous instances of drug-resistant TB. Identifying new drug-resistant TB mutations is challenging given the genetic diversity of TB and the complex mechanisms driving the drug resistance. To address these challenges, here, we aim to develop a machine learning method to predict drug-resistant TB leveraging a large pool of TB genomic data. Additionally, we will explore the underlying metabolic adaptation in drug-resistant TB using genome-scale metabolic modeling.\nResearch Funded by ","date":1672704000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672704000,"objectID":"818ac328f5717af26998e2adb567d76d","permalink":"/research_naamii/tb_drug_resistance/","publishdate":"2023-01-03T00:00:00Z","relpermalink":"/research_naamii/tb_drug_resistance/","section":"research_naamii","summary":"Using systems genomics to understand and better coltrol TB multi-drug resistance","tags":["TB","Tuberculosis","Communicable Disease","Machine Learning","Systems Genomics"],"title":"Predicting drug-resistant Tuberculosis","type":"research_naamii"},{"authors":null,"categories":null,"content":"Mining Dengue virus immunopeptidome for next-generation dengue vaccine Dengue is a viral infection caused by the Dengue virus (DENV), transmitted to humans through the bite of infected mosquitoes, particularly female Aedes aegypti and A. albopictus. Dengue presents an escalating global public health crisis, endangering nearly half of the world\u0026rsquo;s population at a significantly high level of risk. Preventing severe dengue cases by vaccination is crucial for reducing the overall disease burden, minimizing hospitalizations, and saving lives. Currently, available dengue vaccines are ineffective in providing complete immunity against all serotypes of the virus, and their efficacy varies widely across different age groups and prior dengue exposure statuses. Thus, there is an urgent need for a balanced dengue vaccine effective against all DENV serotypes. For this, we aim to discover new molecular targets essential for the development of a more effective next-generation dengue vaccine.\n","date":1672617600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672617600,"objectID":"c43a68368aeac6e0c61b2e890a8b0870","permalink":"/research_naamii/dengue_vaccine/","publishdate":"2023-01-02T00:00:00Z","relpermalink":"/research_naamii/dengue_vaccine/","section":"research_naamii","summary":"Mining Dengue virus immunopeptidome for next-generation dengue vaccine","tags":["Dengue","Immune","Communicable Disease"],"title":"Developing efficient dengue vaccine","type":"research_naamii"},{"authors":null,"categories":null,"content":"Genomic epidemiology of SARS-CoV-2 in Nepal The coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) rapidly escalated into a global pandemic. Nepal detected its first case in January 2020, and since then, the country has grappled with over a million infections and a significant loss of life. Throughout the pandemic, scientists have diligently studied the virus\u0026rsquo;s genetic composition and its evolving transmission patterns. Various geographic regions have experienced multiple waves of infection, each dominated by a novel virus variant. Notably, some of these emerging strains pose challenges to the effectiveness of existing vaccines. Understanding these variants, their origins, and their spread within communities is crucial for future pandemic preparedness. In Nepal, researchers have made significant progress by sharing thousands of SARS-CoV-2 genome sequences publicly. However, comprehensive investigation on these cases has not been conducted till date. This study aims to conduct a comprehensive genomic analysis of SARS-CoV-2 transmission in Nepal. We will investigate virus\u0026rsquo;s genetic diversity, evolutionary trajectory, and epidemiological patterns. Our long-term vision is to create bioinformatics pipelines and platforms which could be readily deployed in case of any future epidemics or pandemics which will help us understand the transmission of the infectious disease and enable rapid intervention of the disease. Toward this goal, we have created the “Nepal SARS-CoV-2 Genome Database”, a comprehensive phylogenetic clustering of SARS-CoV-2 genomes from Nepal using Nextstrain, a powerful open-source tool for the real-time interactive visualization of genome sequencing data.\n","date":1672531200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672531200,"objectID":"bc2d26f94c429f47d08c651507dd53da","permalink":"/research_naamii/covid19_genomics/","publishdate":"2023-01-01T00:00:00Z","relpermalink":"/research_naamii/covid19_genomics/","section":"research_naamii","summary":"Understanding transmission patterns of SARS-CoV-2","tags":["COVID19","SARS","Communicable Disease"],"title":"Genomic epidemiology to understand virus evolution","type":"research_naamii"},{"authors":[],"categories":null,"content":"","date":1669280400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1669280400,"objectID":"68636e3771a3e90fb12abd0d2ef84e81","permalink":"/talk/20221124_biomedicum/","publishdate":"2022-11-25T00:00:00Z","relpermalink":"/talk/20221124_biomedicum/","section":"talk","summary":"","tags":[],"title":"Bioinformatics for Predision Oncology","type":"talk"},{"authors":["M Sjostrom","SG Zhao","S Levy","M Zhang","Y Ning","Raunak Shrestha","A Lundberg","C Herberts","A Foye","R Aggarwal","JT Hua","H Li","A Bergamaschi","C Maurice-Dror","A Maheshwari","S Chen","SWS Ng","W Ye","J Petricca","M Fraser","L Chesner","MD Perry","T Moreno-Rodriguez","WS Chen","JJ Alumkal","J Chou","AK Morgans","TM Beer","GV Thomas","M Gleave","P Lloyd","T Phillips","E McCarthy","MC Haffner","A Zoubeidi","M Annala","RE Reiter","MB Rettig","ON Witte","L Fong","R Bose","FW Huang","J Luo","A Bjartell","JM Lang","NP Mahajan","PN Lara","CP Evans","PT Tran","EM Posadas","C He","X Cui","J Huang","W Zwart","LA Gilbert","CA Maher","PC Boutros","KN Chi","A Ashworth","EJ Small","HH He","AW Wyatt","DA Quigley","FY Feng"],"categories":null,"content":"","date":1667347200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1667347200,"objectID":"2d1f6e98020191c44f03a973ea3df888","permalink":"/publication/2022_prostate5hmc/","publishdate":"2022-11-02T00:00:00Z","relpermalink":"/publication/2022_prostate5hmc/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"The 5-Hydroxymethylcytosine Landscape of Prostate Cancer","type":"publication"},{"authors":["Raunak Shrestha"],"categories":["grant"],"content":"The Prostate Cancer Foundation (PCF) today announced the Class of 2022 Young Investigator Award recipients totaling $7.2 million in funding for innovative prostate cancer research.\nPCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the field of prostate cancer research vibrant with new ideas and offer career and project support for early career physicians and scientists who are committed to advancing the prostate cancer field. Thirty-four PCF Young Investigator Awards totaling $7.2 million were granted to the promising next generation of cancer researchers.\nRaunak Shrestha, PhD was one of the PCF-Young Investigator awardee. His research award was generously sponsored by Mr. Todd Boehly\nPCF-Young Investigator Class of 2022\n","date":1666828800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1666828800,"objectID":"8436688584a199095656bb8a4f53ce75","permalink":"/post/pcfyi_2022/","publishdate":"2022-10-27T00:00:00Z","relpermalink":"/post/pcfyi_2022/","section":"post","summary":"PCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the field of prostate cancer research vibrant with new ideas and offer career and project support for early career physicians and scientists who are committed to advancing the prostate cancer field.","tags":["pcf"],"title":"Raunak Shrestha receives Todd Boehly - Prostate Cancer Foundation Young Investigator Award - 2022","type":"post"},{"authors":[],"categories":null,"content":"","date":1666688400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1666688400,"objectID":"929d8b74212cc835eaa641129d6eb5a2","permalink":"/talk/20221025_pcf_retreat/","publishdate":"2022-07-28T00:00:00Z","relpermalink":"/talk/20221025_pcf_retreat/","section":"talk","summary":"","tags":[],"title":"29th Annual PCF Scientific Retreat","type":"talk"},{"authors":[],"categories":null,"content":"","date":1639958400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1639958400,"objectID":"2224002b58a8aaa6f2c389131250efc8","permalink":"/talk/20211229_ai_ktm/","publishdate":"2021-12-18T00:00:00Z","relpermalink":"/talk/20211229_ai_ktm/","section":"talk","summary":"","tags":[],"title":"Third Nepal Winter-School in AI","type":"talk"},{"authors":["N Rydzewski","JM Lang","M Yu","M Sjostrom","SL Chang","W Chen","Raunak Shrestha","M Zhang","DA Quigley","R Aggarwal","E Small","DR Wahl","FY Feng","SG Zhao"],"categories":null,"content":"","date":1632182400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1632182400,"objectID":"b3cf9ef370d777d1a1817d5e752a6cf7","permalink":"/publication/2021_target/","publishdate":"2021-09-21T00:00:00Z","relpermalink":"/publication/2021_target/","section":"publication","summary":"","tags":null,"title":"Predicting Cancer Drug TARGETS - TreAtment Response GlmnET Signatures","type":"publication"},{"authors":["R Das","M Sjostrom","Raunak Shrestha","C Yogodzinski","EA Egusa","L Chesner","WS Chen","J Chou","DK Dang","JT Swinderman","A Ge","JT Hua","S Kabir","DA Quigley","EJ Small","A Ashworth","FY Feng","LA Gilbert"],"categories":null,"content":"","date":1627603200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1627603200,"objectID":"52698ddbf44a3cd81976fbcaa6b4bd7f","permalink":"/publication/2021_prostatecrispr/","publishdate":"2021-07-30T00:00:00Z","relpermalink":"/publication/2021_prostatecrispr/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer","type":"publication"},{"authors":["Raunak Shrestha","M Llaurado Fernandez","A Dawson","J Hoenisch","S Volik","Y Lin","S Anderson","H Kim","A Haegert","S Colborne","N Wong","B McConeghy","RH Bell","S Brahmbhatt","C Lee","GE DiMattia","S Le Bihan","GB Morin","CC Collins","MS Carey"],"categories":null,"content":"","date":1610582400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1610582400,"objectID":"546e5c158fc8730a6bc998b0f0e096e6","permalink":"/publication/2021_lgsoc/","publishdate":"2021-01-13T00:00:00Z","relpermalink":"/publication/2021_lgsoc/","section":"publication","summary":"LGSOC is a rare tumor subtype with high case fatality rates in patients with metastatic disease. Here, we use multiomics integration of whole-exome sequencing, RNA sequencing, and mass spectrometry–based proteomics on LGSOC cell lines to elucidate novel biomarkers and therapeutic vulnerabilities.","tags":["Cancer"],"title":"Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability","type":"publication"},{"authors":["WS Chen","WA Haynes","R Waitz","K Kamath","A Vega-Crespo","Raunak Shrestha","M Zhang","A Foye","IB Carretero","IG Perez","M Zhang","SG Zhao","M Sjostrom","DA Quigley","J Chou","TM Beer","M Rettig","M Gleave","CP Evans","P Lara","KN Chi","RE Reiter","JJ Alumkal","R Aggarwal","EJ Small","PS Daugherty","A Ribas","DY Oh","JC Shon","FY Feng"],"categories":null,"content":"","date":1600819200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1600819200,"objectID":"efb6e435fbdd5fb2083e2d97e2e711b0","permalink":"/publication/2020_prostateab/","publishdate":"2020-09-23T00:00:00Z","relpermalink":"/publication/2020_prostateab/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Autoantibody landscape in patients with advanced prostate cancer","type":"publication"},{"authors":["E Hodzic","Raunak Shrestha","S Malikic","CC Collins","K Litchfield","S Turajlic","SC Sahinalp"],"categories":null,"content":"Delighted to share our paper describing an algorithm CONETT to identify Conserved Evolutionary Trajectory Tree from multiple tumors. This paper will be presented at the #ISMB2020 conference next week. @cenksahinalp https://t.co/9uMAoaPDoQ pic.twitter.com/uV1NO23tDe\n\u0026mdash; Raunak Shrestha (@raunakms) July 15, 2020 ","date":1594598400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1594598400,"objectID":"adcfe9b05a4be4dd0e3c5b4a40e0fcc7","permalink":"/publication/2020_conett/","publishdate":"2020-07-13T00:00:00Z","relpermalink":"/publication/2020_conett/","section":"publication","summary":"Delighted to share our paper describing an algorithm CONETT to identify Conserved Evolutionary Trajectory Tree from multiple tumors. This paper will be presented at the #ISMB2020 conference next week. @cenksahinalp https://t.co/9uMAoaPDoQ pic.twitter.com/uV1NO23tDe\n\u0026mdash; Raunak Shrestha (@raunakms) July 15, 2020 ","tags":["Cancer","Algorithms","Networks"],"title":"Identification of Conserved Evolutionary Trajectories in Tumors","type":"publication"},{"authors":[],"categories":null,"content":" ","date":1592733600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1592733600,"objectID":"8752c948629c4a21b2000ac277a098f0","permalink":"/talk/20200621_kubic/","publishdate":"2020-06-21T18:00:00Z","relpermalink":"/talk/20200621_kubic/","section":"talk","summary":" ","tags":[],"title":"Cancer Genomics and Precision Oncology","type":"talk"},{"authors":["Raunak Shrestha","N Nabavi","S Volik","S Anderson","A Haegert","B McConeghy","F Sar","S Brahmbhatt","RH Bell","S Le Bihan","Y Wang","CC Collins","A Churg"],"categories":null,"content":"Happy to share our paper published today on genomic characterization of a rare form of a very rare cancer, Well-Differentiated Papillary Mesothelioma (WDPM) of the Peritoneum https://t.co/khLK683Y4P #mesothelioma #PeritonealMesothelioma #WDPM @Cancers_MDPI pic.twitter.com/7pvE42nLTo\n\u0026mdash; Raunak Shrestha (@raunakms) June 13, 2020 ","date":1592006400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1592006400,"objectID":"20d79ea663dd4d9417c5933c48574b94","permalink":"/publication/2020_wdpm/","publishdate":"2020-06-13T00:00:00Z","relpermalink":"/publication/2020_wdpm/","section":"publication","summary":"WDPM is an uncommon mesothelial proliferation that is most commonly encountered as an incidental finding in the peritoneal cavity. Here we show that WDPMs are neoplasms that are genetically distinct from malignant mesotheliomas.","tags":["Mesothelioma"],"title":"Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma","type":"publication"},{"authors":["RK Shrestha","Raunak Shrestha"],"categories":null,"content":"","date":1589587200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1589587200,"objectID":"0c345eb5147992ad471464971041378e","permalink":"/publication/2020_cookingfuel/","publishdate":"2020-05-16T00:00:00Z","relpermalink":"/publication/2020_cookingfuel/","section":"publication","summary":"","tags":null,"title":"Group segmentation and heterogeneity in the choice of cooking fuels in post-earthquake Nepal","type":"publication"},{"authors":["Raunak Shrestha"],"categories":["Nepal","Infectious Disease"],"content":"Article Published in NepalKhabar April 16, 2020. बैशाख ४, २०७७\nकोरोना भाइरस पहिचानका लागि नेपालमा नमुना संकलनको क्रम बढाउँदै लगिए पनि त्यस अनुपातमा परीक्षण बढाउन सकिएको छैन। यसकाे मुख्य कारण हाे- नेपालमै भएका प्रयोगशाला, उपकरण र दक्ष प्राविधिज्ञको पूर्ण सदुपयोग गर्न नसक्नु।\nअहिले नेपालसहित विश्वका २ सयभन्दा बढी मुलुकमा कोरोना भाइरस (कोभिड-१९) को संक्रमण फैलिएको छ। चीनबाट सुरु भएको यो महामारीको केन्द्र पछिल्लो समय युरोप र अमेरिका बनेका छन्। नेपालमा पनि स्थानीय स्तरमा एक महिला संक्रमित भएसँगै यो महामारी दोस्रो चरणमा प्रवेश गरेको छ।\nकेही दिनयता निरन्तर संक्रमित भेटिन थालेका छन्। यसर्थ कोरोनाविरुद्ध थप सतर्कता अपनाउन र परीक्षण तीव्र पार्न आवश्यक छ। नेपाल सरकारले कोभिड-१९ को संक्रमण पत्ता लगाउन र्‍यापिड डायग्नस्टिक टेस्ट (आरडीटी) र पीसीआर दुवै विधि अपनाएको छ।\nवैज्ञानिक नाम सार्स-कोभ-२ भाइरसको संक्रमण जाँच्ने दुई तरिका छन्: र्‍यापिड डायग्नस्टिक टेस्ट (आरडीटी) र पोलिमरेज चेन रियाक्सन (पीसीआर) टेस्ट। आरडीटी- व्यक्ति वा समुदायमा भाइरस संक्रमण छ कि छैन भनेर गरिने परीक्षण हो। कसैमा भाइरस संक्रमण भएमा उसको शरीरभित्र भाइरससँग लड्न रोग-प्रतिरोधात्मक एन्टिबडी प्रोटिन (आईजीएम र आईजीजी) उत्पादन हुन्छन्। यही एन्टिबडी प्रोटिनको मद्दतले ऊ आफैँ ठीक पनि हुन सक्छ। भविष्यमा पनि यही एन्टिबडी प्रोटिनले कोरोना भाइरस संक्रमणको जोखिम कम गर्छ।\nतर आरडीटी परीक्षणले आजका दिनमा भाइरस संक्रमण छ वा छैन भन्ने सूचना दिन सक्दैन। पीसीआर विधिले भने कोरोना भाइरस छ वा छैन भन्ने जानकारी दिन सक्छ। नयाँ संक्रमण पहिचान गर्न सक्छ। यसका लागि मानिसको नाक वा घाँटी भित्रबाट नमुना (तरल पदार्थ) लिइन्छ।\nनेपालमा प्रयोग भइरहेको आरडीटी विधिले मानिसको रगतमा एन्टिबडी प्रोटिन छ वा छैन भनी परीक्षण गर्छ। कसैमा भाइरस संक्रमण भएमा यो एन्डिबडी प्रोटिन बन्न केही दिन लाग्छ। भाइरस संक्रमण भएको ७ दिनदेखि ६ महिनासम्म (वा योभन्दा पनि बढी) यो एन्डिबडी प्रोटिन मानिसको रगतमा रहिरन्छ। रगतमा यो एन्डिबडी प्रोटिन देखिए, आरडीटी परीक्षणको नतिजा पोजिटिभ आउँछ।\nतर भाइरस संक्रमण भएको १ देखि ७ दिनसम्म आरडीटी परीक्षण गर्दा नतिजा नेगेटिभ आउँछ। किनभने यो भाइरस संक्रमणको प्रारम्भिक चरणमा शरीरभित्र भाइरस भए पनि रगतमा एन्डिबडी प्रोटिन बनिसकेको हुँदैन। त्यसैले आरडीटीमा नेगेटिभ देखिएका हरेक मानिसमा पीसीआर परीक्षण गर्न जरुरी हुन्छ। तर नेपालमा आरडीटीमा नेगेटिभ देखिएका मानिसमा कोभिड-१९ का लक्षण देखिए मात्र फेरि पीसीआर परीक्षण गर्ने गरिएको छ। यसले गर्दा धेरै जना संक्रमित पहिचान गर्नबाट छुटेका हुन सक्छन्।\nहालै वीरगन्जको क्वारेन्टिनमा रहेकी एक महिलालाई आरडीटी परीक्षण गर्दा नतिजा नेगेटिभ आएपछि आफ्नो घर कैलाली पठाइयो, तर फेरि पीसीआर परीक्षण गर्दा नतिजा पोजिटिभ आयो। यसको मतलब ती महिलामा भाइरस संक्रमणको प्रारम्भिक चरणमा थियो, जुन आरडीटीले पहिचान गर्न सकेन। पीसीआरले गर्‍याे।\nभाइरस संक्रमण भएको ७–२१ दिनभित्र आरडीटी परीक्षण गरियो भने नतिजा पोजिटिभ आउँछ। पीसीआर परीक्षण गर्दा पनि पोजिटिभै आउँछ। यसको अर्थ उसमा भाइरस भएको, संक्रमण मध्यम चरणमा रहेको र एन्डिबडी प्रोटिन पनि बनेको प्रमाणित हुन्छ। भाइरस संक्रमण भएको १४–२१ दिन बितिसकेको अवस्थामा आरडीटी परीक्षण गर्दा नतिजा पोजिटिभ आउँछ। तर पीसीआर परीक्षण गर्दा रिपोर्ट नेगेटिभ आउन सक्छ।\nयसको अर्थ उसमा हाल संक्रमण नरहेको वा निको हुने चरणमा रहेको भनी बुझ्न सकिन्छ। अहिले नेपालमा कतिपय स्थानमा भइरहेको पनि यही हो। आरडीटी गर्दा पोजिटिभ देखिन्छ भने पीसीआर गर्दा नेगेटिभ।\nहालै काठमाडौं पेप्सिकोलास्थित सनसिटी अपार्टमेन्टमा एकै परिवारका तीन जना (आमा, छोरा र बुहारी) बेलायतबाट कतार हुँदै काठमाडौं आएको करिब तीन साता बितिसकेको थियो। तीनै जनाको पहिले आरडीटीबाट परीक्षण गर्दा नतिजा पोजिटिभ देखियो, तर पुनः पीसीआर परीक्षण गर्दा आमा र छोरामा कोरोना देखियो भने बुहारीमा देखिएन। यसमा कुनै शंका नरहोस्, तीनै जना संक्रमित हुन्।\nआमा र छोराको शरीरभित्र अहिलेसम्म भाइरस छ, तर बुहारीको शरीरबाट हटिसकेको छ। बुहारीलाई विदेशमै भाइरस संक्रमण भएको र पछि उनीबाट आमा र छोरालाई सरेको (स्थानीय संक्रमण) हुन सक्छ। संक्रमित परिवारका सम्पर्कमा आएका मानिसको आरडीटीबाट परीक्षण गर्दा नतिजा नेगेटिभ आए पनि पुनः पीसीआर परीक्षण गर्न जरुरी छ।\nआरडीटी र पीसीआर दुवै परीक्षणमा नतिजा नेगेटिभ आए मात्र भाइरस संक्रमण नभएको पुष्टि हुन्छ।\nआरडिटी परिक्षण पिसिआर परिक्षण नतिजाको अर्थ नेगेटिभ पोजेटिभ भाइरस संक्रमण भएको १-७ दिन भित्र (प्रारम्भिक चरण) अवस्था, शरिरभित्र आजको दिनमा भाइरस रहेको अवस्था पोजेटिभ पोजेटिभ भाइरस संक्रमण भएको ७-२१ दिन (मध्यम चरण) अवस्था, शरिरभित्र आजको दिनमा भाइरस रहेको अवस्था पोजेटिभ नेगेटिभ भाइरस संक्रमण भएको १४-२१ दिन बितिसकिको अवस्था, शरिरबाट भाइरस हतिसकेको वा बिरामी निकोहुने चरणमा रहेको अवस्था नेगेटिभ नेगेटिभ भाइरस संक्रमण नभएको अवस्था पीसीआरभन्दा आरडीटी परीक्षणको मूल्य धेरै सस्तो पर्छ। आरडीटी परीक्षणको नतिजा २०–२५ मिनेटभित्र निकाल्न सकिन्छ भने पीसीआर परीक्षणको नतिजा १–४ घण्टा लाग्छ। आरडीटी परीक्षण गर्न कुनै बिजुली वा महँगो उपकरण चाहिँदैन र साधारण तालिमप्राप्त ल्याब असिस्टेन्टले यो टेस्ट गर्न सक्छन्। त्यसैले आरडीटी परीक्षण गाउँगाउँमा ठूलो समुदायमा गर्न सकिन्छ। पीसीआर एउटा जटिल प्रविधि हो र यसका लागि सुविधाजनक प्रयोगशाला र विशिष्ट तालिमप्राप्त प्राविधिकको आवश्यकता पर्छ। त्यसैले पीसीआर परीक्षण सुगम क्षेत्रमा मात्र सम्भव छ।\nविज्ञान-प्रविधिमा लगानी गर्ने अवसर नेपाल कोरोना भाइरस महामारीको दोस्रो चरणमा प्रवेश गरेको छ। यतिबेला नेपाल सरकारको पहिलो प्राथमिकता कोरोना भाइरस परीक्षण गरी संक्रमित पहिचान गर्नु हो। प्रारम्भिक दिनमा राष्ट्रिय जनस्वास्थ्य प्रयोगशाला (टेकु) मा मात्र पीसीआर परीक्षण हुन्थ्यो भने अहिले यो सेवा नेपालका ११ स्थानमा विस्तार भइसकेको छ। यो धेरै सकारात्मक कुरो हो। तर कोरोना भाइरस पहिचानका लागि नेपालमा नमुना संकलनको क्रम बढाउँदै लगिए पनि त्यस अनुपातमा परीक्षण बढाउन सकिएको छैन। यसकाे मुख्य कारण हाे- नेपालमै भएका प्रयोगशाला, उपकरण र दक्ष प्राविधिज्ञको पूर्ण सदुपयोग गर्न नसक्नु।\nनेपाल सरकारले हालै खरिद गरेको पीसीआर मेसिन प्रयोग गर्नुभन्दा धेरै अगाडिदेखि नेपालका विभिन्न अस्पताल, विश्वविद्यालय, सरकारी तथा गैरसरकारी र निजी अनुसन्धान केन्द्र गरी करिब २५ स्वास्थ्य संस्थामा अब्बल दर्जाका पीसीआर उपकरण थिए। यीमध्ये केही टेकुको राष्ट्रिय जनस्वास्थ्य प्रयोगशालामा हाल रहेका पीसीआर मेसिनजत्तिकै क्षमताका छन्। यी पीसीआर उपकरण नेपाल सरकारले खरिद गरेको भन्दा धेरै सस्ता पनि छन्। जुन पीसीआर उपकरण सरकारले तुरुन्तै प्रयोग गर्न पनि सक्छ।\nत्यसमाथि नेपालकै विभिन्न विश्वविद्यालयबाट बायोटेक्नोलोजी र मिक्रोबायोलोजीमा दिक्षित, पीसीआर प्रविधिमा तालिमप्राप्त सयौं अनुसन्धानकर्मी तथा प्राविधिज्ञलाई कोरोना भाइरसको परीक्षणमा सघाउन र यसको अध्ययन/अनुसन्धानमा लाग्न सरकारले आह्वान गर्न सक्छ। अमेरिका, बेलायत, जर्मनीजस्ता देशमा कोरोना भाइरसको परीक्षण त्यहाँको सरकारी प्रयोगशालाले मात्र धान्न नसकेर विभिन्न विश्वविद्यालय र निजी कम्पनीको प्रयोगशाला, उपकरण र प्राविधिज्ञलाई उपयोग गरिरहेका छन्।\nनेपाल सरकारले हालै खरिद गरेको पीसीआर उपकरण निकै कम क्षमताको भएको पाइएको छ। यो मेसिनले एकपटकमा एक बिरामीको मात्र नमुना परीक्षण गर्न मिल्छ। चौबीसै घण्टा निरन्तर काम गर्दा एक दिनमा जम्मा २४ बिरामीको मात्र नमुना परीक्षण गर्न मिल्ने देखिन्छ। तर राष्ट्रिय जनस्वास्थ्य प्रयोगशाला र नेपालका विभिन्न अनुसन्धान संस्थामा पहिलेदेखि रहेका पीसीआर उपकरणबाट एकैपटकमा ८०-९० बिरामीका नमुना परीक्षण गर्न सकिन्छ र सम्पूर्ण प्रक्रिया ३-४ घण्टामै सकिन्छ। चौबीसै घण्टा निरन्तर काम गरियाे भने एक दिनमा ४-५ सय बिरामीको नमुना परीक्षण गर्न मिल्छ। सरकारले देखाएको अदूरदर्शिताले कोरोना भाइरसको परीक्षणमा चाहिने सामग्री खरिद प्रक्रियामा नेपाली प्राज्ञिक तथा वैज्ञानिकसँग परामर्शै नगरेको स्पष्ट हुन्छ।\nपीसीआर एउटा महँगो प्रविधि र यसलाई सुविधाजनक प्रयोगशाला चाहिने हुन्छ। पीसीआर प्रविधि कोभिड-१९ बाहेक क्षयरोग, हैजा, मलेरिया, कालाजार, क्यान्सरजस्ता मानिसका रोग तथा पशुपक्षी र गहुँबालीमा लाग्ने रोग पहिचान गर्न पनि प्रयोग गरिन्छ।\nनेपाल सरकारले यसलाई खर्चभन्दा पनि विज्ञान-प्रविधिमा गरिने लगानीका रूपमा लिनुपर्छ। अहिल्यै पर्याप्त लगानी नगरे महामारीको अर्को चरणमा थेग्नै नसक्ने मूल्य चुकाउनुपर्छ। नेपाल विज्ञान-प्रविधिमा विश्व समुदायभन्दा धेरै पछि छ। तसर्थ यो महामारीलाई हामी विज्ञान-प्रविधिमा अधिकतम लगानी गर्ने अवसरका रूपमा सदुपयोग गर्ने कि?\n(डा.श्रेष्ठ अमेरिकास्थित युनिभर्सिटी अफ क्यलिफोर्निया, सानफ्रानसिस्कोमा रिसर्च स्कलरका रूपमा क्यान्सर अनुसन्धानमा संलग्न छन्। साथै बायोटेक्नोलोजी सोसाईटी अफ नेपाल (बिएसएन) सँग पनि आबद्ध छन्।)\n","date":1586995200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1586995200,"objectID":"8394d2d74a6892f27fe054e4e5f62d81","permalink":"/post/covid19_rdt_pcr_tests/","publishdate":"2020-04-16T00:00:00Z","relpermalink":"/post/covid19_rdt_pcr_tests/","section":"post","summary":"कोरोना भाइरस पहिचानका लागि नेपालमा नमुना संकलनको क्रम बढाउँदै लगिए पनि त्यस अनुपातमा परीक्षण बढाउन सकिएको छैन। यसकाे मुख्य कारण हाे- नेपालमै भएका प्रयोगशाला, उपकरण र दक्ष प्राविधिज्ञको पूर्ण सदुपयोग गर्न नसक्नु।","tags":["covid19","Nepal"],"title":"यस्तो अवस्थामा आउँछ आरडीटी नेगेटिभ, पीसीआर पोजिटिभ","type":"post"},{"authors":["NM D’Costa","MR Lowerison","PA Raven","Z Tan","ME Roberts","Raunak Shrestha","MW Urban","CU Monjaras-Avila","HZ Oo","A Hurtado-Coll","C Chavez-Munoz","AI So"],"categories":null,"content":"","date":1581292800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1581292800,"objectID":"e300d089f75b16dc3902d2542549d00d","permalink":"/publication/2020_ybox/","publishdate":"2020-02-10T00:00:00Z","relpermalink":"/publication/2020_ybox/","section":"publication","summary":"","tags":["Cancer"],"title":"Y-box Binding Protein-1 is Crucial in Acquired Drug Resistance Development in Metastatic Clear-Cell Renal Cell Carcinoma","type":"publication"},{"authors":["NM D'Costa","D Cina","Raunak Shrestha","RH Bell","YLin","H Asghari","CU Monjaras-Avila","C Kollmannsberger","F Hach","CI Chavez-Munoz","AI So"],"categories":null,"content":"","date":1580947200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1580947200,"objectID":"242f3cdc8e4fdef8bb5918039b486a0b","permalink":"/publication/2020_rcc/","publishdate":"2020-02-06T00:00:00Z","relpermalink":"/publication/2020_rcc/","section":"publication","summary":"","tags":["Cancer"],"title":"Identification of Predictive Gene Signature to Guide Precision Oncology of Clear-Cell Renal Cell Carcinoma","type":"publication"},{"authors":["PCAWG Consortium"],"categories":null,"content":"Great to co-author this landmark paper from the Pan-Cancer Analysis of Whole Genomes #PCWAG consortium published today in Nature https://t.co/pn5gwNYwHo https://t.co/ea39L5OiHu\n\u0026mdash; Raunak Shrestha (@raunakms) February 5, 2020 ","date":1580860800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1580860800,"objectID":"1e51964deb9a398660bd555f49b315bf","permalink":"/publication/2020_pcawg_nature/","publishdate":"2020-02-05T00:00:00Z","relpermalink":"/publication/2020_pcawg_nature/","section":"publication","summary":"The PCAWG Project, conducted by the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes, employed comprehensive whole genome sequencing and integrated analysis techniques on more than 2,600 primary cancers and their corresponding normal tissues from 38 different tumor types.","tags":["Cancer"],"title":"Pan-cancer Analysis of Whole Genomes","type":"publication"},{"authors":["MA Reyna","D Haan","M Paczkowska","LPC Verbeke","M Vazquez","A Kahraman","S Pulido-Tamayo","J Barenboim","L Wadi","P Dhingra","Raunak Shrestha","G Getz","MS Lawrence","JS Pedersen","MA Rubin","DA Wheeler","S Brunak","JMG Izarzugaza","E Khurana","K Marchal","C von Mering","SC Sahinalp","A Valencia","J Reimand","JM Stuart","BJ Raphael","PCAWG Consortium"],"categories":null,"content":"","date":1580860800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1580860800,"objectID":"076ebb9228899ba58d59d6abe0a31d2e","permalink":"/publication/2020_pcawg_network/","publishdate":"2020-02-05T00:00:00Z","relpermalink":"/publication/2020_pcawg_network/","section":"publication","summary":"","tags":["Algorithms","Networks","Cancer"],"title":"Pathway and network analysis of more than 2,500 whole cancer genomes","type":"publication"},{"authors":["Raunak Shrestha","N Nabavi","Y Lin","F Mo","S Anderson","S Volik","H H Adomat","D Lin","H Xue","X Dong","R Shukin","RH Bell","B McConeghy","A Haegert","S Brahmbhatt","E Li","HZ Oo","A Hurtado-Coll","L Fazli","J Zhou","Y McConnell","A McCart","A Lowy","GB Morin","T Chen","M Daugaard","SC Sahinalp","F Hach","S Le Bihan","ME Gleave","Y Wang","A Churg","CC Collins"],"categories":null,"content":"Our paper describing a potentially new treatment for Peritoneal #Mesothelioma published today in @GenomeMedicine https://t.co/admejVvX5K @VanProstateCtr #PrecisionOncology #Immunotherapy #Cancer #Genomics (1/n) pic.twitter.com/mWrsjpTsr1\n\u0026mdash; Raunak Shrestha (@raunakms) February 18, 2019 Great to see our work ( https://t.co/admejVvX5K ) making a mark in the field. Thanks @MLadanyi @fsanchezvega @MGZauderer for highlighting our work. https://t.co/s1cTVs2TgD #Mesothelioma #PeritonealMesothelioma #Immunotherapy\n\u0026mdash; Raunak Shrestha (@raunakms) March 27, 2019 ","date":1549497600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549497600,"objectID":"fa25a8229c18d0f5baad9878123f702f","permalink":"/publication/2019_mesothelioma/","publishdate":"2019-02-07T00:00:00Z","relpermalink":"/publication/2019_mesothelioma/","section":"publication","summary":"Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer originating from the abdominal lining. Our study revealed that BAP1 could serve as a prognostic and predictive biomarker for immunotherapy in PeM.","tags":["Cancer","Mesothelioma","Precision Oncology"],"title":"BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma","type":"publication"},{"authors":["E Hodzic","Raunak Shrestha","K Zhu","K Cheng","CC Collins","SC Sahinalp"],"categories":null,"content":"Our latest publication in @GigaScience on an algorithm to identify patterns of similarity of molecular alterations between cancer patients. “Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks” #Bioinformatics https://t.co/V1MgtqOLkL pic.twitter.com/IRcUVtbnIG\n\u0026mdash; Raunak Shrestha (@raunakms) April 11, 2019 ","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"58e1aebd2fc7ef2688b6bb866476a07e","permalink":"/publication/2019_cdcap/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/publication/2019_cdcap/","section":"publication","summary":"We introduce a novel combinatorial method, cd-CAP, for simultaneous detection of connected subnetworks of an interaction network where genes exhibit conserved alteration patterns across tumor samples.","tags":["Algorithms","Cancer","Networks"],"title":"Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks","type":"publication"},{"authors":[],"categories":[],"content":"Welcome to Slides academia\nFeatures Efficiently write slides in Markdown 3-in-1: Create, Present, and Publish your slides Supports speaker notes Mobile friendly slides Controls Next: Right Arrow or Space Previous: Left Arrow Start: Home Finish: End Overview: Esc Speaker notes: S Fullscreen: F Zoom: Alt + Click PDF Export: E Code Highlighting Inline code: variable\nCode block:\nporridge = \u0026#34;blueberry\u0026#34; if porridge == \u0026#34;blueberry\u0026#34;: print(\u0026#34;Eating...\u0026#34;) Math In-line math: $x + y = z$\nBlock math:\n$$ f\\left( x \\right) = ;\\frac{{2\\left( {x + 4} \\right)\\left( {x - 4} \\right)}}{{\\left( {x + 4} \\right)\\left( {x + 1} \\right)}} $$\nFragments Make content appear incrementally\n{{% fragment %}} One {{% /fragment %}} {{% fragment %}} **Two** {{% /fragment %}} {{% fragment %}} Three {{% /fragment %}} Press Space to play!\nOne **Two** Three A fragment can accept two optional parameters:\nclass: use a custom style (requires definition in custom CSS) weight: sets the order in which a fragment appears Speaker Notes Add speaker notes to your presentation\n{{% speaker_note %}} - Only the speaker can read these notes - Press `S` key to view {{% /speaker_note %}} Press the S key to view the speaker notes!\nOnly the speaker can read these notes Press S key to view Themes black: Black background, white text, blue links (default) white: White background, black text, blue links league: Gray background, white text, blue links beige: Beige background, dark text, brown links sky: Blue background, thin dark text, blue links night: Black background, thick white text, orange links serif: Cappuccino background, gray text, brown links simple: White background, black text, blue links solarized: Cream-colored background, dark green text, blue links Custom Slide Customize the slide style and background\n{{\u0026lt; slide background-image=\u0026#34;/img/boards.jpg\u0026#34; \u0026gt;}} {{\u0026lt; slide background-color=\u0026#34;#0000FF\u0026#34; \u0026gt;}} {{\u0026lt; slide class=\u0026#34;my-style\u0026#34; \u0026gt;}} Custom CSS Example Let\u0026rsquo;s make headers navy colored.\nCreate assets/css/reveal_custom.css with:\n.reveal section h1, .reveal section h2, .reveal section h3 { color: navy; } Questions? Ask\nDocumentation\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"0e6de1a61aa83269ff13324f3167c1a9","permalink":"/slides/example/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/slides/example/","section":"slides","summary":"An introduction to using academia's Slides feature.","tags":[],"title":"Slides","type":"slides"},{"authors":null,"categories":null,"content":" ","date":1540976400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1540976400,"objectID":"395d5c58ae6603e8d3a0f0c67d59f1d1","permalink":"/talk/20181220_ai_ktm/","publishdate":"2018-10-31T09:00:00Z","relpermalink":"/talk/20181220_ai_ktm/","section":"talk","summary":" ","tags":[],"title":"First Nepal Winter-School in AI","type":"talk"},{"authors":null,"categories":null,"content":"","date":1537866000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1537866000,"objectID":"d685df538c850d94d472a7e6c41d32ea","permalink":"/talk/20180928_terryfox/","publishdate":"2018-09-25T09:00:00Z","relpermalink":"/talk/20180928_terryfox/","section":"talk","summary":"","tags":[],"title":"Inactivation of BAP1 Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma","type":"talk"},{"authors":["Raunak Shrestha"],"categories":["data viz"],"content":"I defended my PhD in Bioinformatics from the University of British Columbia (UBC) on August 2018. My PhD thesis can be accessed from the UBC Library Collections. Here, I attempted to visualize bibliography in my PhD thesis. Hope you will find this interesting and useful.\nDownload the bibliography (.bib) file\nDefine Libraries library(\u0026quot;RefManageR\u0026quot;) library(\u0026quot;dplyr\u0026quot;) Read .bib file file.bib \u0026lt;- file.path(\u0026quot;raunak_shrestha_ubc_phd_thesis_bibliography_2018.bib\u0026quot;) bib \u0026lt;- suppressMessages(RefManageR::ReadBib(file.bib)) Convert bib object to dataframe dat \u0026lt;- as.data.frame(bib, row.names=NULL, optional=FALSE) val.year \u0026lt;- as.numeric(dat$year) Generate histogram of citations by year of publication h \u0026lt;- hist(val.year, breaks=30, plot=FALSE) xfit \u0026lt;- seq(min(val.year), max(val.year), length=30) yfit \u0026lt;- dnorm(xfit, mean=mean(val.year), sd=sd(val.year)) yfit \u0026lt;- yfit*diff(h$mids[1:2])*length(val.year) plot(h, col=c(\u0026quot;#fdbf6f\u0026quot;), main=\u0026quot;\u0026quot;, xlab=\u0026quot;Year of Publication\u0026quot;, ylab=\u0026quot;No. of Citations\u0026quot;, axes=FALSE, cex.main=1, cex.lab=1, cex.axis=1, las=1, tck=-0.03) lines(xfit, yfit, col=\u0026quot;#000000\u0026quot;, lwd=3) axis(side=1, at=seq(1985,2020,3), labels=TRUE, tick=TRUE, cex.axis=1, las=2, lwd=1, tck=-0.03) axis(side=2, at=seq(0,25,5), labels=TRUE, tick=TRUE, cex.axis=1, las=1, lwd=1, tck=-0.03) Distribution of citations by the journal of publication For the sake of visualization, we will restrict to top-20 journals dat1 \u0026lt;- dat[-which(is.na(dat$journal)),] df \u0026lt;- dat1 %\u0026gt;% dplyr::count(journal, sort=TRUE) df20 \u0026lt;- df[1:20,] df20\n## # A tibble: 20 x 2 ## journal n ## \u0026lt;chr\u0026gt; \u0026lt;int\u0026gt; ## 1 Nature 20 ## 2 Bioinformatics 16 ## 3 Nucleic Acids Research 13 ## 4 Nature Genetics 12 ## 5 Cancer Cell 10 ## 6 Science 9 ## 7 PLoS Computational Biology 8 ## 8 Cell 6 ## 9 Genome Research 6 ## 10 Nature Reviews Cancer 6 ## 11 PNAS 5 ## 12 Genome Biology 4 ## 13 Molecular Systems Biology 4 ## 14 AJHG 3 ## 15 Cancer Discovery 3 ## 16 Cancer Research 3 ## 17 Cell Reports 3 ## 18 Clinical Cancer Research 3 ## 19 Nature methods 3 ## 20 PLoS ONE 3 par(mar=c(4,12,2,2)) barplot(rev(df20$n), width=1, names.arg=rev(df20$journal), horiz=TRUE, col=\u0026quot;#fdbf6f\u0026quot;, las=1, main=\u0026quot;\u0026quot;, ylab=\u0026quot;\u0026quot;, xlab=\u0026quot;No. of Citations\u0026quot;, cex.axis=1, cex.names=1, cex.lab=1, tck=-0.03) I later post-processed the R-plots in Adobe Photoshop to get the figure below. ","date":1535760000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1535760000,"objectID":"4d8882916e7bb80aa2a211984391f816","permalink":"/post/bibliography_phdthesis/","publishdate":"2018-09-01T00:00:00Z","relpermalink":"/post/bibliography_phdthesis/","section":"post","summary":"Here, I attempted to visualize bibliography in my PhD thesis","tags":["data viz"],"title":"Visualization of Bibliography in my PhD Thesis","type":"post"},{"authors":["Raunak Shrestha"],"categories":null,"content":"","date":1533772800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1533772800,"objectID":"5a2b0991e8791da5bbde831c3f5c8c53","permalink":"/publication/2018_phdthesis/","publishdate":"2018-08-09T00:00:00Z","relpermalink":"/publication/2018_phdthesis/","section":"publication","summary":"","tags":null,"title":"Computational prioritization of cancer driver genes for precision oncology","type":"publication"},{"authors":null,"categories":null,"content":"Last updated: November 1, 2024\nThis Privacy Policy describes Our policies and procedures on the collection, use and disclosure of Your information when You use the Service and tells You about Your privacy rights and how the law protects You.\nWe use Your Personal data to provide and improve the Service. By using the Service, You agree to the collection and use of information in accordance with this Privacy Policy. This Privacy Policy has been created with the help of the Privacy Policy Generator.\nInterpretation and Definitions Interpretation The words of which the initial letter is capitalized have meanings defined under the following conditions. The following definitions shall have the same meaning regardless of whether they appear in singular or in plural.\nDefinitions For the purposes of this Privacy Policy:\nAccount means a unique account created for You to access our Service or parts of our Service.\nAffiliate means an entity that controls, is controlled by or is under common control with a party, where \u0026ldquo;control\u0026rdquo; means ownership of 50% or more of the shares, equity interest or other securities entitled to vote for election of directors or other managing authority.\nCompany (referred to as either \u0026ldquo;the Company\u0026rdquo;, \u0026ldquo;We\u0026rdquo;, \u0026ldquo;Us\u0026rdquo; or \u0026ldquo;Our\u0026rdquo; in this Agreement) refers to Raunak Shrestha.\nCookies are small files that are placed on Your computer, mobile device or any other device by a website, containing the details of Your browsing history on that website among its many uses.\nCountry refers to: California, United States\nDevice means any device that can access the Service such as a computer, a cellphone or a digital tablet.\nPersonal Data is any information that relates to an identified or identifiable individual.\nService refers to the Website.\nService Provider means any natural or legal person who processes the data on behalf of the Company. It refers to third-party companies or individuals employed by the Company to facilitate the Service, to provide the Service on behalf of the Company, to perform services related to the Service or to assist the Company in analyzing how the Service is used.\nThird-party Social Media Service refers to any website or any social network website through which a User can log in or create an account to use the Service.\nUsage Data refers to data collected automatically, either generated by the use of the Service or from the Service infrastructure itself (for example, the duration of a page visit).\nWebsite refers to Raunak Shrestha, accessible from https://raunakms.github.io/\nYou means the individual accessing or using the Service, or the company, or other legal entity on behalf of which such individual is accessing or using the Service, as applicable.\nCollecting and Using Your Personal Data Types of Data Collected Personal Data While using Our Service, We may ask You to provide Us with certain personally identifiable information that can be used to contact or identify You. Personally identifiable information may include, but is not limited to:\nUsage Data Usage Data Usage Data is collected automatically when using the Service.\nUsage Data may include information such as Your Device\u0026rsquo;s Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Service that You visit, the time and date of Your visit, the time spent on those pages, unique device identifiers and other diagnostic data.\nWhen You access the Service by or through a mobile device, We may collect certain information automatically, including, but not limited to, the type of mobile device You use, Your mobile device unique ID, the IP address of Your mobile device, Your mobile operating system, the type of mobile Internet browser You use, unique device identifiers and other diagnostic data.\nWe may also collect information that Your browser sends whenever You visit our Service or when You access the Service by or through a mobile device.\nInformation from Third-Party Social Media Services The Company allows You to create an account and log in to use the Service through the following Third-party Social Media Services:\nGoogle Facebook Instagram Twitter LinkedIn If You decide to register through or otherwise grant us access to a Third-Party Social Media Service, We may collect Personal data that is already associated with Your Third-Party Social Media Service\u0026rsquo;s account, such as Your name, Your email address, Your activities or Your contact list associated with that account.\nYou may also have the option of sharing additional information with the Company through Your Third-Party Social Media Service\u0026rsquo;s account. If You choose to provide such information and Personal Data, during registration or otherwise, You are giving the Company permission to use, share, and store it in a manner consistent with this Privacy Policy.\nTracking Technologies and Cookies We use Cookies and similar tracking technologies to track the activity on Our Service and store certain information. Tracking technologies used are beacons, tags, and scripts to collect and track information and to improve and analyze Our Service. The technologies We use may include:\nCookies or Browser Cookies. A cookie is a small file placed on Your Device. You can instruct Your browser to refuse all Cookies or to indicate when a Cookie is being sent. However, if You do not accept Cookies, You may not be able to use some parts of our Service. Unless you have adjusted Your browser setting so that it will refuse Cookies, our Service may use Cookies. Web Beacons. Certain sections of our Service and our emails may contain small electronic files known as web beacons (also referred to as clear gifs, pixel tags, and single-pixel gifs) that permit the Company, for example, to count users who have visited those pages or opened an email and for other related website statistics (for example, recording the popularity of a certain section and verifying system and server integrity). Cookies can be \u0026ldquo;Persistent\u0026rdquo; or \u0026ldquo;Session\u0026rdquo; Cookies. Persistent Cookies remain on Your personal computer or mobile device when You go offline, while Session Cookies are deleted as soon as You close Your web browser. You can learn more about cookies on TermsFeed website article.\nWe use both Session and Persistent Cookies for the purposes set out below:\nNecessary / Essential Cookies\nType: Session Cookies\nAdministered by: Us\nPurpose: These Cookies are essential to provide You with services available through the Website and to enable You to use some of its features. They help to authenticate users and prevent fraudulent use of user accounts. Without these Cookies, the services that You have asked for cannot be provided, and We only use these Cookies to provide You with those services.\nCookies Policy / Notice Acceptance Cookies\nType: Persistent Cookies\nAdministered by: Us\nPurpose: These Cookies identify if users have accepted the use of cookies on the Website.\nFunctionality Cookies\nType: Persistent Cookies\nAdministered by: Us\nPurpose: These Cookies allow us to remember choices You make when You use the Website, such as remembering your login details or language preference. The purpose of these Cookies is to provide You with a more personal experience and to avoid You having to re-enter your preferences every time You use the Website.\nFor more information about the cookies we use and your choices regarding cookies, please visit our Cookies Policy or the Cookies section of our Privacy Policy.\nUse of Your Personal Data The Company may use Personal Data for the following purposes:\nTo provide and maintain our Service, including to monitor the usage of our Service.\nTo manage Your Account: to manage Your registration as a user of the Service. The Personal Data You provide can give You access to different functionalities of the Service that are available to You as a registered user.\nFor the performance of a contract: the development, compliance and undertaking of the purchase contract for the products, items or services You have purchased or of any other contract with Us through the Service.\nTo contact You: To contact You by email, telephone calls, SMS, or other equivalent forms of electronic communication, such as a mobile application\u0026rsquo;s push notifications regarding updates or informative communications related to the functionalities, products or contracted services, including the security updates, when necessary or reasonable for their implementation.\nTo provide You with news, special offers and general information about other goods, services and events which we offer that are similar to those that you have already purchased or enquired about unless You have opted not to receive such information.\nTo manage Your requests: To attend and manage Your requests to Us.\nFor business transfers: We may use Your information to evaluate or conduct a merger, divestiture, restructuring, reorganization, dissolution, or other sale or transfer of some or all of Our assets, whether as a going concern or as part of bankruptcy, liquidation, or similar proceeding, in which Personal Data held by Us about our Service users is among the assets transferred.\nFor other purposes: We may use Your information for other purposes, such as data analysis, identifying usage trends, determining the effectiveness of our promotional campaigns and to evaluate and improve our Service, products, services, marketing and your experience.\nWe may share Your personal information in the following situations:\nWith Service Providers: We may share Your personal information with Service Providers to monitor and analyze the use of our Service, to contact You. For business transfers: We may share or transfer Your personal information in connection with, or during negotiations of, any merger, sale of Company assets, financing, or acquisition of all or a portion of Our business to another company. With Affiliates: We may share Your information with Our affiliates, in which case we will require those affiliates to honor this Privacy Policy. Affiliates include Our parent company and any other subsidiaries, joint venture partners or other companies that We control or that are under common control with Us. With business partners: We may share Your information with Our business partners to offer You certain products, services or promotions. With other users: when You share personal information or otherwise interact in the public areas with other users, such information may be viewed by all users and may be publicly distributed outside. If You interact with other users or register through a Third-Party Social Media Service, Your contacts on the Third-Party Social Media Service may see Your name, profile, pictures and description of Your activity. Similarly, other users will be able to view descriptions of Your activity, communicate with You and view Your profile. With Your consent: We may disclose Your personal information for any other purpose with Your consent. Retention of Your Personal Data The Company will retain Your Personal Data only for as long as is necessary for the purposes set out in this Privacy Policy. We will retain and use Your Personal Data to the extent necessary to comply with our legal obligations (for example, if we are required to retain your data to comply with applicable laws), resolve disputes, and enforce our legal agreements and policies.\nThe Company will also retain Usage Data for internal analysis purposes. Usage Data is generally retained for a shorter period of time, except when this data is used to strengthen the security or to improve the functionality of Our Service, or We are legally obligated to retain this data for longer time periods.\nTransfer of Your Personal Data Your information, including Personal Data, is processed at the Company\u0026rsquo;s operating offices and in any other places where the parties involved in the processing are located. It means that this information may be transferred to — and maintained on — computers located outside of Your state, province, country or other governmental jurisdiction where the data protection laws may differ than those from Your jurisdiction.\nYour consent to this Privacy Policy followed by Your submission of such information represents Your agreement to that transfer.\nThe Company will take all steps reasonably necessary to ensure that Your data is treated securely and in accordance with this Privacy Policy and no transfer of Your Personal Data will take place to an organization or a country unless there are adequate controls in place including the security of Your data and other personal information.\nDelete Your Personal Data You have the right to delete or request that We assist in deleting the Personal Data that We have collected about You.\nOur Service may give You the ability to delete certain information about You from within the Service.\nYou may update, amend, or delete Your information at any time by signing in to Your Account, if you have one, and visiting the account settings section that allows you to manage Your personal information. You may also contact Us to request access to, correct, or delete any personal information that You have provided to Us.\nPlease note, however, that We may need to retain certain information when we have a legal obligation or lawful basis to do so.\nDisclosure of Your Personal Data Business Transactions If the Company is involved in a merger, acquisition or asset sale, Your Personal Data may be transferred. We will provide notice before Your Personal Data is transferred and becomes subject to a different Privacy Policy.\nLaw enforcement Under certain circumstances, the Company may be required to disclose Your Personal Data if required to do so by law or in response to valid requests by public authorities (e.g. a court or a government agency).\nOther legal requirements The Company may disclose Your Personal Data in the good faith belief that such action is necessary to:\nComply with a legal obligation Protect and defend the rights or property of the Company Prevent or investigate possible wrongdoing in connection with the Service Protect the personal safety of Users of the Service or the public Protect against legal liability Security of Your Personal Data The security of Your Personal Data is important to Us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While We strive to use commercially acceptable means to protect Your Personal Data, We cannot guarantee its absolute security.\nChildren\u0026rsquo;s Privacy Our Service does not address anyone under the age of 13. We do not knowingly collect personally identifiable information from anyone under the age of 13. If You are a parent or guardian and You are aware that Your child has provided Us with Personal Data, please contact Us. If We become aware that We have collected Personal Data from anyone under the age of 13 without verification of parental consent, We take steps to remove that information from Our servers.\nIf We need to rely on consent as a legal basis for processing Your information and Your country requires consent from a parent, We may require Your parent\u0026rsquo;s consent before We collect and use that information.\nLinks to Other Websites Our Service may contain links to other websites that are not operated by Us. If You click on a third party link, You will be directed to that third party\u0026rsquo;s site. We strongly advise You to review the Privacy Policy of every site You visit.\nWe have no control over and assume no responsibility for the content, privacy policies or practices of any third party sites or services.\nChanges to this Privacy Policy We may update Our Privacy Policy from time to time. We will notify You of any changes by posting the new Privacy Policy on this page.\nWe will let You know via email and/or a prominent notice on Our Service, prior to the change becoming effective and update the \u0026ldquo;Last updated\u0026rdquo; date at the top of this Privacy Policy.\nYou are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.\nContact Us If you have any questions about this Privacy Policy, You can contact me.\n","date":1530140400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1530140400,"objectID":"18d05a63a1c8d7ed973cc51838494e41","permalink":"/privacy/","publishdate":"2018-06-28T00:00:00+01:00","relpermalink":"/privacy/","section":"","summary":"Last updated: November 1, 2024\nThis Privacy Policy describes Our policies and procedures on the collection, use and disclosure of Your information when You use the Service and tells You about Your privacy rights and how the law protects You.\nWe use Your Personal data to provide and improve the Service. By using the Service, You agree to the collection and use of information in accordance with this Privacy Policy. This Privacy Policy has been created with the help of the Privacy Policy Generator.","tags":null,"title":"Privacy Policy","type":"page"},{"authors":null,"categories":null,"content":"I will be giving a talk at \u0026ldquo;MS09 - Peritoneal Mesothelioma\u0026rdquo; parallel mini-symposia at iMig2018 (May 4, 2018: Provinces II - Level 4, 11:00 - 12:30).\n","date":1525431600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1525431600,"objectID":"5a239c1b41a89080d346e7bc4877a732","permalink":"/talk/20180502_imig/","publishdate":"2018-05-04T11:00:00Z","relpermalink":"/talk/20180502_imig/","section":"talk","summary":"I will be giving a talk at \u0026ldquo;MS09 - Peritoneal Mesothelioma\u0026rdquo; parallel mini-symposia at iMig2018 (May 4, 2018: Provinces II - Level 4, 11:00 - 12:30).","tags":[],"title":"BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal Mesothelioma","type":"talk"},{"authors":["EE Gill","LS Chan","GL Winsor","N Dobson","R Lo","SJH Sui","BK Dhillon","PK Taylor","Raunak Shrestha","CoSpencer","REW Hancock","PJ Unrau","FSL Brinkman"],"categories":null,"content":"","date":1522108800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1522108800,"objectID":"476820afa15f49480effda15ed98f210","permalink":"/publication/2018_rnabacteria/","publishdate":"2018-03-27T00:00:00Z","relpermalink":"/publication/2018_rnabacteria/","section":"publication","summary":"","tags":null,"title":"High-throughput detection of RNA processing in bacteria","type":"publication"},{"authors":["H Sharifi-Noghabi","Y Liu","N Erho","Raunak Shrestha","M Alshalalfa","E Davicioni","CC Collins","M Ester"],"categories":null,"content":"","date":1519862400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1519862400,"objectID":"94e6484399256ff273f436e746db8626","permalink":"/publication/2018_dgs/","publishdate":"2018-03-01T00:00:00Z","relpermalink":"/publication/2018_dgs/","section":"publication","summary":"","tags":["Machine Learning","Prostate Cancer"],"title":"Deep Genomic Signature for early metastasis prediction in Prostate Cancer","type":"publication"},{"authors":["M Yamada","J Tang","J Lugo-Martinez","E Hodzic","Raunak Shrestha","A Saha","H Ouyang","D Yin","H Mamitsuka","SC Sahinalp","P Radivojac","F Menczer","Y Chang"],"categories":null,"content":"","date":1515369600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1515369600,"objectID":"e098ba55dfd99acd030be3ecb2272fb2","permalink":"/publication/2018_featureselection/","publishdate":"2018-01-08T00:00:00Z","relpermalink":"/publication/2018_featureselection/","section":"publication","summary":"","tags":["Machine Learning"],"title":"Ultra High-Dimensional Nonlinear Feature Selection for Big Biological Data","type":"publication"},{"authors":null,"categories":null,"content":"I will be giving a talk at the Terry Fox Research Institute 8th Annual Scientific Meeting (ASM). Also check for my poster during poster sessions.\n","date":1509879600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509879600,"objectID":"9aca54bcc4b9cdb98533391866e498ef","permalink":"/talk/20171105_ccrc/","publishdate":"2017-11-05T11:00:00Z","relpermalink":"/talk/20171105_ccrc/","section":"talk","summary":"I will be giving a talk at the Terry Fox Research Institute 8th Annual Scientific Meeting (ASM). Also check for my poster during poster sessions.","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"talk"},{"authors":null,"categories":null,"content":"I will be giving a talk at the Terry Fox Research Institute [8th Annual Scientific Meeting (ASM)].\n","date":1509793200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509793200,"objectID":"930e44605b545d36095a9ab1332005a1","permalink":"/talk/20171104_tfri/","publishdate":"2017-11-04T11:00:00Z","relpermalink":"/talk/20171104_tfri/","section":"talk","summary":"I will be giving a talk at the Terry Fox Research Institute [8th Annual Scientific Meeting (ASM)].","tags":[],"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"talk"},{"authors":null,"categories":null,"content":"","date":1509534000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509534000,"objectID":"6a6c27516c3c15046cacaaa90bad28a0","permalink":"/talk/20171101_cshl/","publishdate":"2017-11-01T11:00:00Z","relpermalink":"/talk/20171101_cshl/","section":"talk","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"talk"},{"authors":["Raunak Shrestha","E Hodzic","T Sauerwald","P Dao","K Wang","J Yeung","S Anderson","F Vandin","G Haffari","CC Collins","SC Sahinalp"],"categories":null,"content":" Here goes my paper that got published in @genomeresearch today :D https://t.co/yY8Ipch2Eg #Bioinformatics #Genomics #PrecisionOncology pic.twitter.com/ZxDCjzrQn6\n\u0026mdash; Raunak Shrestha (@raunakms) July 18, 2017 Our paper highlighted in @CellSystemsCP \u0026quot;Identifying Rare Cancer Drivers\u0026quot; https://t.co/5ob895KjS4 #Bioinformatics #precisionmedicine pic.twitter.com/pW3rZuNneo\n\u0026mdash; Raunak Shrestha (@raunakms) August 23, 2017 ","date":1500336000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1500336000,"objectID":"bb068087471aa1ea1144a30b6829638a","permalink":"/publication/2017_hitndrive/","publishdate":"2017-07-18T00:00:00Z","relpermalink":"/publication/2017_hitndrive/","section":"publication","summary":"An algorithm to identify cancer driver genes in individual cancer patients by measuring the influence of gene alterations on perturbing transcriptional networks.","tags":["Algorithms","Cancer","Precision Oncology"],"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"publication"},{"authors":null,"categories":null,"content":"","date":1487323800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1487323800,"objectID":"9f972da2fef7b7c2504a10fd461d63f8","permalink":"/talk/20170217_terryfox/","publishdate":"2017-02-17T09:30:00Z","relpermalink":"/talk/20170217_terryfox/","section":"talk","summary":"","tags":null,"title":"Translating Big-Data to Precision Oncology","type":"talk"},{"authors":null,"categories":null,"content":"","date":1478196000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1478196000,"objectID":"806c18087bdf403409af2a7223857d77","permalink":"/talk/20161103_vanbug/","publishdate":"2016-11-03T18:00:00Z","relpermalink":"/talk/20161103_vanbug/","section":"talk","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"talk"},{"authors":null,"categories":null,"content":"","date":1476781200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1476781200,"objectID":"8827ac6c4c703fa1c21703de2786a71d","permalink":"/talk/20161018_ashg/","publishdate":"2016-10-18T09:00:00Z","relpermalink":"/talk/20161018_ashg/","section":"talk","summary":"","tags":null,"title":"ASHG-2016","type":"talk"},{"authors":null,"categories":null,"content":"","date":1475485200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1475485200,"objectID":"13e328420320f5b82402bd94d9f08781","permalink":"/talk/20161003_giw/","publishdate":"2016-10-03T09:00:00Z","relpermalink":"/talk/20161003_giw/","section":"talk","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"talk"},{"authors":["ISU Luk","Raunak Shrestha","H Xue","Y Wang","F Zhang","D Lin","A Haegert","R Wu","X Dong","CC Collins","A Zoubeidi","ME Gleave","PW Gout","Y Wang"],"categories":null,"content":"","date":1474588800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1474588800,"objectID":"76d9847c9264e4c7e51195c46c2ac9ff","permalink":"/publication/2016_birc6/","publishdate":"2016-09-23T00:00:00Z","relpermalink":"/publication/2016_birc6/","section":"publication","summary":"","tags":["Cancer"],"title":"BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer","type":"publication"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"a903a8fd061907c9182a22fe4aed4729","permalink":"/project/artificial-intelligence/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/artificial-intelligence/","section":"project","summary":"Lorem ipsum dolor sit amet consectetur adipisicing elit. Magnam, eius.","tags":["Demo","robotics"],"title":"Artificial Intelligence","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"cbe0c24c174e9c23efd27e59e7e56acc","permalink":"/project/deep-learning/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/deep-learning/","section":"project","summary":"Lorem ipsum dolor sit amet consectetur adipisicing elit. Magnam, eius.","tags":["Demo","Deep Learning"],"title":"Deep Learning","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"d1311ddf745551c9e117aa4bb7e28516","permalink":"/project/external-project/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/external-project/","section":"project","summary":"An example of linking directly to an external project website using \"external_link\".","tags":["Demo"],"title":"External Project","type":"project"},{"authors":null,"categories":null,"content":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"8f66d660a9a2edc2d08e68cc30f701f7","permalink":"/project/internal-project/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/internal-project/","section":"project","summary":"An example of using the in-built project page.","tags":["Deep Learning"],"title":"Internal Project","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"2deecdf5e31bc09985d9db8bcee07248","permalink":"/project/robotics/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/robotics/","section":"project","summary":"Lorem ipsum dolor sit amet consectetur adipisicing elit. Magnam, eius.","tags":["Robotics"],"title":"Robotics","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"e3d2cb9f760d662f43826965ea291872","permalink":"/project/skin-cancer-ai/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/skin-cancer-ai/","section":"project","summary":"Lorem ipsum dolor sit amet consectetur adipisicing elit. Magnam, eius.","tags":["human"],"title":"Skin Cancer AI","type":"project"},{"authors":["Raunak Shrestha"],"categories":["networks","data viz"],"content":"Genomic knowledge are often curated in the form of Genes. For example, a geneset of genes mapping to the chromosome locus chr8q24; a geneset of genes known to involve in DNA Repair Module, etc. Similarly, this data structure is also representative of patient-Genes data.\nThis can be thought of as a bipartite graph representing relation between individual Module to a gene. Often bioinformaticians are interested to visualize if there is any kind of relation between the Modules. This problem can be modeled as the conversion of two-mode network (bipartite graph) to one-mode network of Modules and visualize the resulting one-mode network. Here, I attempt to demonstrate how this can be achieved using R.\nDetails in github project\nLoad required libraries library(\u0026quot;stringr\u0026quot;) library(\u0026quot;igraph\u0026quot;) library(\u0026quot;RColorBrewer\u0026quot;) library(\u0026quot;gplots\u0026quot;) library(\u0026quot;cluster\u0026quot;) Load input data file #file.dat \u0026lt;- url(\u0026quot;https://dl.dropboxusercontent.com/u/30823824/dat_Genes.txt\u0026quot;) file.dat \u0026lt;- \u0026quot;data_table.tsv\u0026quot; dat \u0026lt;- read.delim(file.dat, header=TRUE, stringsAsFactors=FALSE) str(dat) ## 'data.frame': 37 obs. of 2 variables: ## $ SampleID: chr \u0026quot;T-01\u0026quot; \u0026quot;T-02\u0026quot; \u0026quot;T-03\u0026quot; \u0026quot;T-04\u0026quot; ... ## $ Genes : chr \u0026quot;FOXA1:GATA3:XBP1:COX17:KATNAL1:SCO2:STAT6:TFF3:THY1\u0026quot; \u0026quot;AR:NCOA3:SPDEF:TFF1:XBP1\u0026quot; \u0026quot;AR:FOXA1:MAP3K1:SP1:VAV3\u0026quot; \u0026quot;ESR1:LRBA:UBC:XBP1:ZFYVE16\u0026quot; ... Compute bipartite graph get.bip \u0026lt;- function(df){ ids \u0026lt;- df$SampleID genes \u0026lt;- sort(unique(unlist(str_split(df$Genes, \u0026quot;:\u0026quot;))),decreasing=F) bip \u0026lt;- matrix(0, nrow=length(ids), ncol=length(genes), dimnames=list(ids, genes))\nlist.genes \u0026lt;- str_split(df$Genes, \u0026quot;:\u0026quot;) list.gene.index \u0026lt;- lapply(list.genes, function(x) which(colnames(bip) %in% x))\nfor(i in 1:length(list.gene.index)){ bip[i,list.gene.index[[i]]] \u0026lt;- 1 } return(bip) }\nbip \u0026lt;- get.bip(dat)\nbip[1:5,1:5]\n## ABCC8 ADCY9 AKAP6 ALCAM APOB ## T-01 0 0 0 0 0 ## T-02 0 0 0 0 0 ## T-03 0 0 0 0 0 ## T-04 0 0 0 0 0 ## T-05 0 0 0 0 0 #dat$TotalGenes \u0026lt;- unlist(lapply(list.gene.index, length)) #dat$Color \u0026lt;- rev(jColFun(nrow(dat.sub))) jColFun \u0026lt;- colorRampPalette(brewer.pal(n = 9, \u0026quot;Purples\u0026quot;)) #Plot heatmap of the bi-partite graph heatmap.2(bip, col = jColFun(256), Colv=TRUE, Rowv = TRUE, dendrogram =\u0026quot;both\u0026quot;, trace=\u0026quot;none\u0026quot;, key=\u0026quot;FALSE\u0026quot;, hclustfun = function(x) hclust(x, method = \u0026quot;ward.D2\u0026quot;), distfun = function(x) dist(x, method = \u0026quot;binary\u0026quot;), colsep=c(1:500), rowsep=c(1:500), sepcolor=\u0026quot;grey90\u0026quot;, sepwidth=c(0.05,0.05), cexRow=0.7, cexCol=0.3) Compute CSI: Connection Specific Index # First compute pearson correlation dat.pcc \u0026lt;- cor(t(bip), method=\u0026quot;pearson\u0026quot;) dat.pcc[1:5,1:5] ## T-01 T-02 T-03 T-04 T-05 ## T-01 1.00000000 0.10974355 0.10974355 0.10974355 -0.02916748 ## T-02 0.10974355 1.00000000 0.17260274 0.17260274 -0.02144028 ## T-03 0.10974355 0.17260274 1.00000000 -0.03424658 -0.02144028 ## T-04 0.10974355 0.17260274 -0.03424658 1.00000000 -0.02144028 ## T-05 -0.02916748 -0.02144028 -0.02144028 -0.02144028 1.00000000 # Function to compute CSI: Connection Specific Index ### get.csi \u0026lt;- function(dat){ mat \u0026lt;- matrix(0, nrow=nrow(dat), ncol=ncol(dat), dimnames=list(rownames(dat),colnames(dat))) for(i in 1:nrow(dat)){ a \u0026amp;lt;- rownames(dat)[i] for(j in 1:ncol(dat)){ b \u0026amp;lt;- colnames(dat)[j] pcc.ab \u0026amp;lt;- dat[a,b] - 0.05 conn.pairs.a \u0026amp;lt;- colnames(dat)[which(dat[a,] \u0026amp;gt;= pcc.ab)] conn.pairs.b \u0026amp;lt;- rownames(dat)[which(dat[,b] \u0026amp;gt;= pcc.ab)] conn.pairs.ab \u0026amp;lt;- length(union(conn.pairs.a,conn.pairs.b)) n \u0026amp;lt;- nrow(dat) csi \u0026amp;lt;- 1 - (conn.pairs.ab/n) mat[i,j] \u0026amp;lt;- csi } } return(mat) }\ndat.csi \u0026lt;- get.csi(dat.pcc) dat.csi[1:5,1:5]\n## T-01 T-02 T-03 T-04 T-05 ## T-01 0.9729730 0.5405405 0.5675676 0.5945946 0.000000 ## T-02 0.5405405 0.9729730 0.5405405 0.5675676 0.000000 ## T-03 0.5675676 0.5405405 0.9729730 0.0000000 0.000000 ## T-04 0.5945946 0.5675676 0.0000000 0.9729730 0.000000 ## T-05 0.0000000 0.0000000 0.0000000 0.0000000 0.972973 heatmap.2(as.matrix(dat.pcc), col = jColFun(256), Colv=TRUE, Rowv = TRUE, dendrogram =\u0026quot;both\u0026quot;, trace=\u0026quot;none\u0026quot;, hclustfun = function(x) hclust(x, method = \u0026quot;ward.D2\u0026quot;), distfun = function(x) dist(x, method = \u0026quot;minkowski\u0026quot;, p=2), colsep=c(1:500), rowsep=c(1:500), sepcolor=\u0026quot;white\u0026quot;, sepwidth=c(0.05,0.05), key=\u0026quot;FALSE\u0026quot;,cexRow=0.8, cexCol=0.8, main=\u0026quot;PCC\u0026quot;) heatmap.2(as.matrix(dat.csi), col = jColFun(256), Colv=TRUE, Rowv = TRUE, dendrogram =\u0026quot;both\u0026quot;, trace=\u0026quot;none\u0026quot;, hclustfun = function(x) hclust(x, method = \u0026quot;ward.D2\u0026quot;), distfun = function(x) dist(x, method = \u0026quot;minkowski\u0026quot;, p=2), colsep=c(1:500), rowsep=c(1:500), sepcolor=\u0026quot;white\u0026quot;, sepwidth=c(0.05,0.05), key=\u0026quot;FALSE\u0026quot;,cexRow=0.8, cexCol=0.8, main=\u0026quot;CSI\u0026quot;) Visualizing the network #Convert the adjacency (corellation) matrix to an igraph object g \u0026lt;- graph.adjacency(dat.csi, mode = \u0026quot;undirected\u0026quot;, weighted=TRUE, diag=FALSE) g \u0026lt;- simplify(g, edge.attr.comb=list(weight=\u0026quot;sum\u0026quot;)) #get the node size ratio #for(ctr in 1:length(V(g)$name)){ # index \u0026lt;- which(dat$Module == V(g)$name[ctr]) # V(g)$size[ctr] \u0026lt;- dat$TotalGenes[index] # V(g)$color[ctr] \u0026lt;- dat$Color[index] #} V(g)$size \u0026lt;- 5 Set vertex attributes V(g)$label \u0026lt;- V(g)$name V(g)$label.color \u0026lt;- \u0026quot;black\u0026quot; V(g)$label.cex \u0026lt;- .8 V(g)$label.dist \u0026lt;- 0.3 V(g)$label.family \u0026lt;- \u0026quot;Helvetica\u0026quot; V(g)$frame.color \u0026lt;- \u0026quot;grey\u0026quot;\nE(g)$color \u0026lt;- rgb(.6,.6,0,E(g)$weight) E(g)$width \u0026lt;- E(g)$weight * 5\nGenerate Graph Output File file.graph.output \u0026lt;- \u0026quot;graph_projection.gml\u0026quot; write_graph(graph=g, file=file.graph.output, format=\u0026quot;gml\u0026quot;) plot(g, layout=layout.kamada.kawai) ## Warning in text.default(x[v], y[v], labels = if1(labels, v), col = ## if1(label.color, : font family not found in Windows font database Details in github project\n","date":1461110400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461110400,"objectID":"7db7485fe761d33fa600884e274183b4","permalink":"/post/projections/","publishdate":"2016-04-20T00:00:00Z","relpermalink":"/post/projections/","section":"post","summary":"Often bioinformaticians are interested to visualize if there is any kind of relation between the Modules. This problem can be modeled as the conversion of two-mode network (bipartite graph) to one-mode network of Modules and visualize the resulting one-mode network. Here, I attempt to demonstrate how this can be achieved using R.","tags":["bioinformatics","data viz","networks"],"title":"Visualize and cluster one-mode projection of a bi-partite graph","type":"post"},{"authors":null,"categories":null,"content":"","date":1460451600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1460451600,"objectID":"6630e9042afc2cdd50554c44d0a2c1ac","permalink":"/talk/20160411_simons/","publishdate":"2016-04-12T09:00:00Z","relpermalink":"/talk/20160411_simons/","section":"talk","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization to Guide Precision Cancer Medicine","type":"talk"},{"authors":null,"categories":null,"content":"","date":1460019600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1460019600,"objectID":"bf954d88f35cc8c15e6f888b42ee80c6","permalink":"/talk/20160407_pcawg/","publishdate":"2016-04-07T09:00:00Z","relpermalink":"/talk/20160407_pcawg/","section":"talk","summary":"","tags":null,"title":"PCAWG-2016","type":"talk"},{"authors":["AW Wyatt","F Mo","K Wang","B McConeghy","S Brahmbhatt","L Jong","DM Mitchell","RL Johnston","A Haegert","E Li","J Liew","J Yeung","Raunak Shrestha","A Lapuk","A McPherson","R Shukin","RH Bell","S Anderson","J Bishop","A Hurtado-Coll","H Xiao","AM Chinnaiyan","R Mehra","D Lin","Y Wang","L Fazli","ME Gleave","S Volik","CC Collins"],"categories":null,"content":"","date":1409011200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1409011200,"objectID":"6b2d277c452c3166d1664f3c6869ba2c","permalink":"/publication/2014_highriskpca/","publishdate":"2014-08-26T00:00:00Z","relpermalink":"/publication/2014_highriskpca/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer","type":"publication"},{"authors":["K Wang","Raunak Shrestha","AW Wyatt","A Reddy","J Lehar","Y Wang","A Lapuk","CC Collins"],"categories":null,"content":"","date":1405641600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1405641600,"objectID":"b6d8ab1da5a3e0ed4e4c4b8a51ebd4c5","permalink":"/publication/2014_drugresp/","publishdate":"2014-07-18T00:00:00Z","relpermalink":"/publication/2014_drugresp/","section":"publication","summary":"","tags":["Cancer"],"title":"A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines","type":"publication"},{"authors":["Raunak Shrestha","E Hodzic","J Yeung","K Wang","T Sauerwald","P Dao","S Anderson","H Beltran","MA Rubin","CC Collins","G Haffari","SC Sahinalp"],"categories":null,"content":"","date":1396310400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1396310400,"objectID":"4b3dfd6441f8860b07a24e56568ab042","permalink":"/publication/2014_hitndrive/","publishdate":"2014-04-01T00:00:00Z","relpermalink":"/publication/2014_hitndrive/","section":"publication","summary":"","tags":["Algorithms","Precision Oncology"],"title":"HIT'nDRIVE: Multi-driver gene prioritization based on hitting time","type":"publication"},{"authors":["Raunak Shrestha","RN Joshi","K Joshi","BH Poudel","BG Shrestha"],"categories":null,"content":"","date":1295308800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1295308800,"objectID":"05f33ea04fcb080831eb2d035ac84cfd","permalink":"/publication/2011_mtb/","publishdate":"2011-01-18T00:00:00Z","relpermalink":"/publication/2011_mtb/","section":"publication","summary":"","tags":null,"title":"Analysis of KatG Ser315Thr Mutation in Multidrug Resistant Mycobacterium tuberculosis and SLC11A1 Polymorphism in Multidrug Resistance Tuberculosis in Central Development Region of Nepal Using PCR-RFLP Technique: A Pilot Study","type":"publication"}]